1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 100−00−5 : 1−Chloro−4−nitrobenzene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 100−00−5 : 1−Chloro−4−nitrobenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 100−01−6 : 4−Nitroaniline Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 100−01−6 : 4−Nitroaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 100−02−7 : 4−Nitrophenol Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 100−02−7 : 4−Nitrophenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 10016−20−3 : alpha−Cyclodextrin Chemical QC [ N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 10016−20−3 : alpha−Cyclodextrin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 100−21−0 : Terephthalic acid Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 100−21−0 : Terephthalic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 10025−74−8 : Dysprosium(III) chloride Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 10025−74−8 : Dysprosium(III) chloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 100−37−8 : N,N−Diethylethanolamine Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 100−37−8 : N,N−Diethylethanolamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 10042−59−8 : 2−Propyl−1−heptanol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 10042−59−8 : 2−Propyl−1−heptanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 10043−35−3 : Boric acid Chemical QC [ N.D. N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 10043−35−3 : Boric acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 100−51−6 : Benzyl alcohol Chemical QC [ N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 100−51−6 : Benzyl alcohol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 100−54−9 : 3−Pyridinecarbonitrile Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 100−54−9 : 3−Pyridinecarbonitrile Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 100−64−1 : Cyclohexanone oxime Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 100−64−1 : Cyclohexanone oxime Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1007−28−9 : Deisopropylatrazine Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1007−28−9 : Deisopropylatrazine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 10081−67−1 : 4−(2−Phenylpropan−2−yl)−N−[4−(2−phenylpropan−2−yl)phenyl]aniline Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 10081−67−1 : 4−(2−Phenylpropan−2−yl)−N−[4−(2−phenylpropan−2−yl)phenyl]aniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1008−72−6 : Sodium 2−formylbenzenesulfonate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1008−72−6 : Sodium 2−formylbenzenesulfonate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 10094−34−5 : 1,1−Dimethyl−2−phenylethyl butanoate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 10094−34−5 : 1,1−Dimethyl−2−phenylethyl butanoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 100−97−0 : Methenamine

Chemical QC [ N.D. N.D. N.D. N.D. P−MW ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 100−97−0 : Methenamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−02−0 : Triphenyl phosphite Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−02−0 : Triphenyl phosphite Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−05−3 : Anilazine Chemical QC [ ? ? P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−05−3 : Anilazine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−10−0 : Cloprop Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−10−0 : Cloprop Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−20−2 : Triclocarban Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−20−2 : Triclocarban Agonist: 0 Antagonist: 0.052

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−21−3 : Chlorpropham Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−21−3 : Chlorpropham Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−37−1 : 2,4,6−Tris(allyloxy)−1,3,5−triazine Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−37−1 : 2,4,6−Tris(allyloxy)−1,3,5−triazine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−42−8 : Fenuron Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−42−8 : Fenuron Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101463−69−8 : Flufenoxuron Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101463−69−8 : Flufenoxuron Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−54−2 : N−Phenyl−1,4−benzenediamine Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−54−2 : N−Phenyl−1,4−benzenediamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−55−3 : p−Bromodiphenyl ether Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−55−3 : p−Bromodiphenyl ether Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−61−1 : 4,4'−Methylenebis(N,N−dimethylaniline) Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−61−1 : 4,4'−Methylenebis(N,N−dimethylaniline) Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 10161−33−8 : 17beta−Trenbolone Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 10161−33−8 : 17beta−Trenbolone Agonist: 1.1 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−77−9 : 4,4'−Methylenedianiline Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−77−9 : 4,4'−Methylenedianiline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−80−4 : 4,4'−Oxydianiline Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−80−4 : 4,4'−Oxydianiline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−81−5 : Diphenylmethane Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−81−5 : Diphenylmethane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−83−7 : Dicyclohexylamine Chemical QC [ ? N.D. N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−83−7 : Dicyclohexylamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−84−8 : Diphenyl oxide Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−84−8 : Diphenyl oxide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−86−0 : 2−Benzylideneoctanal Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 101−86−0 : 2−Benzylideneoctanal Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 102−06−7 : 1,3−Diphenylguanidine Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 102−06−7 : 1,3−Diphenylguanidine Agonist: 0 Antagonist: 0.047

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 10222−01−2 : 2,2−Dibromo−3−nitrilopropionamide Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 10222−01−2 : 2,2−Dibromo−3−nitrilopropionamide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 102−27−2 : N−Ethyl−3−methylaniline Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 102−27−2 : N−Ethyl−3−methylaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 102409−92−7 : FR073317 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 102409−92−7 : FR073317 Agonist: 0 Antagonist: 0.052

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1024−57−3 : Heptachlor epoxide Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1024−57−3 : Heptachlor epoxide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 102−60−3 : N,N,N',N'−Tetrakis(2−Hydroxypropyl)ethylenediamine Chemical QC [ N.D. N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 102−60−3 : N,N,N',N'−Tetrakis(2−Hydroxypropyl)ethylenediamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 10265−92−6 : Methamidophos Chemical QC [ N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 10265−92−6 : Methamidophos Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 102676−31−3 : Fadrozole hydrochloride Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 102676−31−3 : Fadrozole hydrochloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 102−71−6 : Triethanolamine Chemical QC [ N.D. N.D. N.D. P−MW ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 102−71−6 : Triethanolamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 102−76−1 : Triacetin Chemical QC [ ? N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 102−76−1 : Triacetin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 102−82−9 : Tributylamine Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 102−82−9 : Tributylamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 103055−07−8 : Lufenuron Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 103055−07−8 : Lufenuron Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 103−09−3 : 2−Ethylhexyl acetate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 103−09−3 : 2−Ethylhexyl acetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1031−07−8 : Endosulfan sulfate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1031−07−8 : Endosulfan sulfate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 103−11−7 : 2−Ethylhexyl acrylate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 103−11−7 : 2−Ethylhexyl acrylate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 103−23−1 : Di(2−ethylhexyl) adipate Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 103−23−1 : Di(2−ethylhexyl) adipate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 103−24−2 : Bis(2−ethylhexyl) nonanedioate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 103−24−2 : Bis(2−ethylhexyl) nonanedioate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 103−33−3 : Azobenzene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 103−33−3 : Azobenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 103−34−4 : 4,4'−Dithiodimorpholine Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 103−34−4 : 4,4'−Dithiodimorpholine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 103361−09−7 : Flumioxazin Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 103361−09−7 : Flumioxazin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1034−01−1 : Octyl gallate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1034−01−1 : Octyl gallate Agonist: 0 Antagonist: 0.00024

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 103−41−3 : Benzyl cinnamate Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 103−41−3 : Benzyl cinnamate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 103−65−1 : Propylbenzene Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 103−65−1 : Propylbenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 103−69−5 : N−Ethylaniline Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 103−69−5 : N−Ethylaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 103−76−4 : 1−Piperazineethanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 103−76−4 : 1−Piperazineethanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 103−90−2 : Acetaminophen Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 103−90−2 : Acetaminophen Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 104098−48−8 : Imazapic Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 104098−48−8 : Imazapic Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 104−13−2 : 4−Butylaniline Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 104−13−2 : 4−Butylaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 104206−82−8 : Mesotrione Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 104206−82−8 : Mesotrione Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 104−40−5 : 4−Nonylphenol Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 104−40−5 : 4−Nonylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 104−43−8 : 4−Dodecylphenol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 104−43−8 : 4−Dodecylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 104−45−0 : 4−Propylanisole Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 104−45−0 : 4−Propylanisole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 104−51−8 : Butylbenzene Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 104−51−8 : Butylbenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 10453−86−8 : Resmethrin Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 10453−86−8 : Resmethrin Agonist: 0 Antagonist: 0.041

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 104−54−1 : 3−Phenyl−2−propen−1−ol Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 104−54−1 : 3−Phenyl−2−propen−1−ol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 104−61−0 : gamma−Nonanolactone Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 104−61−0 : gamma−Nonanolactone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 104−66−5 : 1,2−Diphenoxyethane Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 104−66−5 : 1,2−Diphenoxyethane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 104−67−6 : 5−Heptyldihydro−2(3H)−furanone Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 104−67−6 : 5−Heptyldihydro−2(3H)−furanone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 104−76−7 : 2−Ethyl−1−hexanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 104−76−7 : 2−Ethyl−1−hexanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 104795−68−8 : CI−959 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 104795−68−8 : CI−959 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 105−21−5 : 1,4−Heptanolide Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 105−21−5 : 1,4−Heptanolide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 105−37−3 : Ethyl propionate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 105−37−3 : Ethyl propionate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 10540−29−1 : Tamoxifen Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 10540−29−1 : Tamoxifen Agonist: 0.019 Antagonist: 0.046

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 105512−06−9 : Clodinafop−propargyl mixt. Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 105512−06−9 : Clodinafop−propargyl mixt. Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 105−53−3 : Diethyl propanedioate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 105−53−3 : Diethyl propanedioate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 105−54−4 : Ethyl butyrate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 105−54−4 : Ethyl butyrate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 105−55−5 : N,N'−Diethylthiourea Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 105−55−5 : N,N'−Diethylthiourea Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 105−60−2 : Caprolactam Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 105−60−2 : Caprolactam Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 105624−86−0 : 5HPP−33 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 105624−86−0 : 5HPP−33 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 105−67−9 : 2,4−Dimethylphenol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 105−67−9 : 2,4−Dimethylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 105−87−3 : Geranyl acetate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 105−87−3 : Geranyl acetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 105−99−7 : Dibutyl hexanedioate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 105−99−7 : Dibutyl hexanedioate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 10605−21−7 : Carbendazim Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 10605−21−7 : Carbendazim Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1061517−62−1 : PharmaGSID_47337 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1061517−62−1 : PharmaGSID_47337 Agonist: 0 Antagonist: 0.039

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1062243−51−9 : PharmaGSID_48511 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1062243−51−9 : PharmaGSID_48511 Agonist: 0 Antagonist: 0.23

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−22−9 : Citronellol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−22−9 : Citronellol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−23−0 : Citronellal Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−23−0 : Citronellal Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−24−1 : Geraniol Chemical QC [ N.D. N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−24−1 : Geraniol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−25−2 : (2Z)−3,7−Dimethylocta−2,6−dien−1−ol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−25−2 : (2Z)−3,7−Dimethylocta−2,6−dien−1−ol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−27−4 : Isopentyl butyrate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−27−4 : Isopentyl butyrate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−30−9 : Ethyl heptanoate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−30−9 : Ethyl heptanoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−43−4 : 4−Chlorotoluene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−43−4 : 4−Chlorotoluene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−44−5 : p−Cresol Chemical QC [ N.D. N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−44−5 : p−Cresol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−45−6 : 4−Thiocresol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−45−6 : 4−Thiocresol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−46−7 : 1,4−Dichlorobenzene Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−46−7 : 1,4−Dichlorobenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−47−8 : 4−Chloroaniline Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−47−8 : 4−Chloroaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−48−9 : 4−Chlorophenol Chemical QC [ ? N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−48−9 : 4−Chlorophenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−49−0 : 4−Methylaniline Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−49−0 : 4−Methylaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−50−3 : 1,4−Benzenediamine Chemical QC [ ? N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−50−3 : 1,4−Benzenediamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−65−0 : Dimethyl succinate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−65−0 : Dimethyl succinate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−68−3 : 3−Octanone Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−68−3 : 3−Octanone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1067−25−0 : Trimethoxypropylsilane Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1067−25−0 : Trimethoxypropylsilane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1067−53−4 : Tris(2−methoxyethoxy)vinylsilane Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1067−53−4 : Tris(2−methoxyethoxy)vinylsilane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−87−6 : 4−Vinyl−1−cyclohexene dioxide Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−87−6 : 4−Vinyl−1−cyclohexene dioxide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1068967−96−3 : SAR102608 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1068967−96−3 : SAR102608 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−93−4 : 1,2−Dibromoethane Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 106−93−4 : 1,2−Dibromoethane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107071−66−9 : Ro 23−7637 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107071−66−9 : Ro 23−7637 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−07−3 : 2−Chloroethanol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−07−3 : 2−Chloroethanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−13−1 : Acrylonitrile Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−13−1 : Acrylonitrile Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−18−6 : Allyl alcohol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−18−6 : Allyl alcohol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−20−0 : Chloroacetaldehyde Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−20−0 : Chloroacetaldehyde Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−21−1 : Ethylene glycol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−21−1 : Ethylene glycol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1072−15−7 : Sulfuric acid, monononyl ester, sodium salt Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1072−15−7 : Sulfuric acid, monononyl ester, sodium salt Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−30−2 : Chloromethyl methyl ether Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−30−2 : Chloromethyl methyl ether Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−41−5 : 2−Methyl−2,4−pentanediol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−41−5 : 2−Methyl−2,4−pentanediol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−46−0 : Hexamethyldisiloxane Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−46−0 : Hexamethyldisiloxane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−51−7 : Octamethyltrisiloxane Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−51−7 : Octamethyltrisiloxane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107534−96−3 : Tebuconazole Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107534−96−3 : Tebuconazole Agonist: 0.0019 Antagonist: 0.12

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−54−0 : 3,5−Dimethyl−1−hexyn−3−ol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−54−0 : 3,5−Dimethyl−1−hexyn−3−ol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1076−97−7 : 1,4−Cyclohexanedicarboxylic acid Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1076−97−7 : 1,4−Cyclohexanedicarboxylic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−75−5 : 7−Hydroxy−3,7−dimethyloctanal Chemical QC [ ? N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−75−5 : 7−Hydroxy−3,7−dimethyloctanal Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−87−9 : 2−Pentanone Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−87−9 : 2−Pentanone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−88−0 : 1,3−Butanediol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−88−0 : 1,3−Butanediol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−92−6 : Butanoic acid Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−92−6 : Butanoic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−98−2 : 1−Methoxy−2−propanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 107−98−2 : 1−Methoxy−2−propanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−01−0 : Dimethylaminoethanol Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−01−0 : Dimethylaminoethanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−11−2 : 4−Methyl−2−pentanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−11−2 : 4−Methyl−2−pentanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−21−4 : Isopropyl acetate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−21−4 : Isopropyl acetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−32−7 : Propylene carbonate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−32−7 : Propylene carbonate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−38−3 : 1,3−Dimethylbenzene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−38−3 : 1,3−Dimethylbenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−39−4 : m−Cresol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−39−4 : m−Cresol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108419−33−6 : Acetic acid, C8−10−branched alkyl esters, C9−rich Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108419−33−6 : Acetic acid, C8−10−branched alkyl esters, C9−rich Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−44−1 : 3−Methylaniline Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−44−1 : 3−Methylaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−45−2 : 1,3−Benzenediamine Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−45−2 : 1,3−Benzenediamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−46−3 : Resorcinol Chemical QC [ N.D. N.D. N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−46−3 : Resorcinol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1085−12−7 : Heptylparaben Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1085−12−7 : Heptylparaben Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−59−8 : Dimethyl malonate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−59−8 : Dimethyl malonate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−67−8 : 1,3,5−Trimethylbenzene Chemical QC [ N.D. N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−67−8 : 1,3,5−Trimethylbenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−68−9 : 3,5−Dimethylphenol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−68−9 : 3,5−Dimethylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−77−0 : 2,4,6−Trichloro−s−triazine Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−77−0 : 2,4,6−Trichloro−s−triazine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−80−5 : Cyanuric acid Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−80−5 : Cyanuric acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−83−8 : Diisobutyl ketone Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−83−8 : Diisobutyl ketone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−91−8 : Cyclohexylamine Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−91−8 : Cyclohexylamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−93−0 : Cyclohexanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−93−0 : Cyclohexanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−94−1 : Cyclohexanone Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−94−1 : Cyclohexanone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−95−2 : Phenol Chemical QC [ N.D. N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−95−2 : Phenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−98−5 : Benzenethiol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−98−5 : Benzenethiol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−99−6 : 3−Methylpyridine Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 108−99−6 : 3−Methylpyridine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 109−02−4 : 4−Methylmorpholine Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 109−02−4 : 4−Methylmorpholine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 109−43−3 : Dibutyl decanedioate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 109−43−3 : Dibutyl decanedioate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 109−46−6 : N,N'−Dibutylthiourea Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 109−46−6 : N,N'−Dibutylthiourea Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 109−52−4 : Pentanoic acid Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 109−52−4 : Pentanoic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 109−55−7 : 3−(Dimethylamino)propylamine Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 109−55−7 : 3−(Dimethylamino)propylamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1095−90−5 : Methadone hydrochloride Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1095−90−5 : Methadone hydrochloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 109−77−3 : Propanedinitrile Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 109−77−3 : Propanedinitrile Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 109−86−4 : 2−Methoxyethanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 109−86−4 : 2−Methoxyethanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−05−4 : Di−tert−butyl peroxide Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−05−4 : Di−tert−butyl peroxide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−12−3 : 5−Methyl−2−hexanone Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−12−3 : 5−Methyl−2−hexanone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−15−6 : Butanedioic acid Chemical QC [ N.D. N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−15−6 : Butanedioic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−16−7 : Maleic acid Chemical QC [ N.D. N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−16−7 : Maleic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−17−8 : Fumaric acid Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−17−8 : Fumaric acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110235−47−7 : Mepanipyrim Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110235−47−7 : Mepanipyrim Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−25−8 : Oleyl sarcosine Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−25−8 : Oleyl sarcosine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−26−9 : N,N'−Methylenebisacrylamide Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−26−9 : N,N'−Methylenebisacrylamide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−27−0 : Isopropyl tetradecanoic acid Chemical QC [ ? N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−27−0 : Isopropyl tetradecanoic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−33−8 : Dihexyl hexanedioate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−33−8 : Dihexyl hexanedioate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−42−9 : Methyl decanoate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−42−9 : Methyl decanoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−43−0 : 2−Heptanone Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−43−0 : 2−Heptanone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−44−1 : Sorbic acid Chemical QC [ N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−44−1 : Sorbic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110488−70−5 : Dimethomorph Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110488−70−5 : Dimethomorph Agonist: 0 Antagonist: 0.061

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−62−3 : Pentanal Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−62−3 : Pentanal Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−63−4 : 1,4−Butanediol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−63−4 : 1,4−Butanediol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−65−6 : 2−Butyne−1,4−diol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−65−6 : 2−Butyne−1,4−diol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−69−0 : Butanal oxime Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−69−0 : Butanal oxime Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−73−6 : 2−(Ethylamino)ethanol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−73−6 : 2−(Ethylamino)ethanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−80−5 : 2−Ethoxyethanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−80−5 : 2−Ethoxyethanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−85−0 : Piperazine Chemical QC [ N.D. N.D. N.D. P−MW ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−85−0 : Piperazine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−87−2 : 3,4−Dihydro−2H−pyran Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−87−2 : 3,4−Dihydro−2H−pyran Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−91−8 : Morpholine Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−91−8 : Morpholine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−97−4 : Diisopropanolamine Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 110−97−4 : Diisopropanolamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 11099−07−3 : Glyceryl stearates Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 11099−07−3 : Glyceryl stearates Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−11−5 : Methyl octanoate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−11−5 : Methyl octanoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−14−8 : Heptanoic acid Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−14−8 : Heptanoic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−15−9 : 2−Ethoxyethyl acetate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−15−9 : 2−Ethoxyethyl acetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1111−78−0 : Ammonium carbamate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1111−78−0 : Ammonium carbamate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−20−6 : Decanedioic acid Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−20−6 : Decanedioic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−21−7 : Triethylene glycol diacetate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−21−7 : Triethylene glycol diacetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1112−39−6 : Dimethoxydimethylsilane Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1112−39−6 : Dimethoxydimethylsilane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−27−3 : 1−Hexanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−27−3 : 1−Hexanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−30−8 : Glutaraldehyde Chemical QC [ ? N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−30−8 : Glutaraldehyde Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−40−0 : Diethylenetriamine Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−40−0 : Diethylenetriamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−42−2 : Diethanolamine Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−42−2 : Diethanolamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−44−4 : Bis(2−chloroethyl) ether Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−44−4 : Bis(2−chloroethyl) ether Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−46−6 : Diethylene glycol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−46−6 : Diethylene glycol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1114−71−2 : Pebulate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1114−71−2 : Pebulate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−49−9 : Hexamethyleneimine Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−49−9 : Hexamethyleneimine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−55−7 : 1,2−Ethanediol diacetate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−55−7 : 1,2−Ethanediol diacetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−62−6 : Ethyl oleate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−62−6 : Ethyl oleate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−69−3 : Hexanedinitrile Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−69−3 : Hexanedinitrile Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−70−6 : 1−Heptanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−70−6 : 1−Heptanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−71−7 : Heptanal Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−71−7 : Heptanal Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−76−2 : 2−Butoxyethanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−76−2 : 2−Butoxyethanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−77−3 : Diethylene glycol monomethyl ether Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−77−3 : Diethylene glycol monomethyl ether Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111812−58−9 : Fenpyroximate (Z,E) Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111812−58−9 : Fenpyroximate (Z,E) Agonist: 0 Antagonist: 0.079

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−82−0 : Methyl dodecanoate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−82−0 : Methyl dodecanoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−84−2 : Nonane Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−84−2 : Nonane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1118−46−3 : Butyltin trichloride Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1118−46−3 : Butyltin trichloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−87−5 : 1−Octanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−87−5 : 1−Octanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1118−92−9 : N,N−Dimethyloctanamide Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1118−92−9 : N,N−Dimethyloctanamide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−90−0 : 2−(2−Ethoxyethoxy)ethanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−90−0 : 2−(2−Ethoxyethoxy)ethanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1119−40−0 : Dimethyl glutarate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1119−40−0 : Dimethyl glutarate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−96−6 : Bis(2−methoxyethyl) ether Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111−96−6 : Bis(2−methoxyethyl) ether Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111988−49−9 : Thiacloprid Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111988−49−9 : Thiacloprid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111991−09−4 : Nicosulfuron Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 111991−09−4 : Nicosulfuron Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1120−01−0 : Sodium hexyldecyl sulfate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1120−01−0 : Sodium hexyldecyl sulfate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1120−04−3 : Octadecyl sulfate sodium salt Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1120−04−3 : Octadecyl sulfate sodium salt Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−00−5 : Dodecyltrimethylammonium chloride Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−00−5 : Dodecyltrimethylammonium chloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1120−21−4 : Undecane Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1120−21−4 : Undecane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1120−36−1 : 1−Tetradecene Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1120−36−1 : 1−Tetradecene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−05−0 : Nonanoic acid Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−05−0 : Nonanoic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1120−71−4 : 1,3−Propane sultone Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1120−71−4 : 1,3−Propane sultone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−07−2 : 2−Butoxyethyl acetate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−07−2 : 2−Butoxyethyl acetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−12−9 : 2−Undecanone Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−12−9 : 2−Undecanone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−14−1 : Octyl acetate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−14−1 : Octyl acetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−18−5 : N,N−Dimethyldodecan−1−amine Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−18−5 : N,N−Dimethyldodecan−1−amine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112226−61−6 : Halofenozide Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112226−61−6 : Halofenozide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−25−4 : 2−(Hexyloxy)ethanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−25−4 : 2−(Hexyloxy)ethanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−27−6 : Triethylene glycol Chemical QC [ N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−27−6 : Triethylene glycol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112281−77−3 : Tetraconazole Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112281−77−3 : Tetraconazole Agonist: 0 Antagonist: 0.23

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−30−1 : 1−Decanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−30−1 : 1−Decanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−31−2 : Decanal Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−31−2 : Decanal Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−34−5 : 2−(2−Butoxyethoxy)ethanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−34−5 : 2−(2−Butoxyethoxy)ethanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−35−6 : 2−[2−(2−Methoxyethoxy)ethoxy]ethanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−35−6 : 2−[2−(2−Methoxyethoxy)ethoxy]ethanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−38−9 : 10−Undecenoic acid Chemical QC [ ? N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−38−9 : 10−Undecenoic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112410−23−8 : Tebufenozide Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112410−23−8 : Tebufenozide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−42−5 : 1−Undecanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−42−5 : 1−Undecanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−49−2 : Triethylene glycol dimethyl ether Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−49−2 : Triethylene glycol dimethyl ether Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−50−5 : 2−[2−(2−Ethoxyethoxy)ethoxy]ethanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−50−5 : 2−[2−(2−Ethoxyethoxy)ethoxy]ethanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112529−15−4 : Pioglitazone hydrochloride Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112529−15−4 : Pioglitazone hydrochloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−53−8 : 1−Dodecanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−53−8 : 1−Dodecanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−55−0 : 1−Dodecanethiol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−55−0 : 1−Dodecanethiol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−60−7 : Tetraethylene glycol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−60−7 : Tetraethylene glycol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−63−0 : Methyl linoleate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−63−0 : Methyl linoleate Agonist: 0 Antagonist: 0.037

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−70−9 : 1−Tridecanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−70−9 : 1−Tridecanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−72−1 : 1−Tetradecanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−72−1 : 1−Tetradecanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112733−06−9 : Zenarestat Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112733−06−9 : Zenarestat Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−80−1 : Oleic acid Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112−80−1 : Oleic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112809−51−5 : Letrozole Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 112809−51−5 : Letrozole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 113136−77−9 : Cyclanilide Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 113136−77−9 : Cyclanilide Agonist: 0 Antagonist: 0.00011

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1134−23−2 : Cycloate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1134−23−2 : Cycloate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 113−48−4 : MGK−264 Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 113−48−4 : MGK−264 Agonist: 0 Antagonist: 0.057

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 113734−18−2 : CP−114271 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 113734−18−2 : CP−114271 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 114−07−8 : Erythromycin Chemical QC [ ? ? ? P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 114−07−8 : Erythromycin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 114−26−1 : Propoxur Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 114−26−1 : Propoxur Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 114311−32−9 : Imazamox Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 114311−32−9 : Imazamox Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1143−38−0 : Anthralin Chemical QC [ ? N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1143−38−0 : Anthralin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 114369−43−6 : Fenbuconazole Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 114369−43−6 : Fenbuconazole Agonist: 0 Antagonist: 0.043

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 115−28−6 : Chlorendic acid Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 115−28−6 : Chlorendic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 115−29−7 : Endosulfan Chemical QC [ ? N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 115−29−7 : Endosulfan Agonist: 0 Antagonist: 0.028

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 115−32−2 : Dicofol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 115−32−2 : Dicofol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 115−39−9 : Bromophenol blue Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 115−39−9 : Bromophenol blue Agonist: 0 Antagonist: 0.051

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1156−19−0 : Tolazamide Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1156−19−0 : Tolazamide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 115−77−5 : Pentaerythritol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 115−77−5 : Pentaerythritol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 115−86−6 : Triphenyl phosphate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 115−86−6 : Triphenyl phosphate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 115−95−7 : Linalyl acetate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 115−95−7 : Linalyl acetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 115−96−8 : Tris(2−chloroethyl) phosphate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 115−96−8 : Tris(2−chloroethyl) phosphate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 116−02−9 : 3,3,5−Trimethylcyclohexanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 116−02−9 : 3,3,5−Trimethylcyclohexanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 116−06−3 : Aldicarb Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 116−06−3 : Aldicarb Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 116255−48−2 : Bromuconazole Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 116255−48−2 : Bromuconazole Agonist: 0 Antagonist: 0.14

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 116−25−6 : 1−(Hydroxymethyl)−5,5−dimethylhydantoin Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 116−25−6 : 1−(Hydroxymethyl)−5,5−dimethylhydantoin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1166−52−5 : Dodecyl gallate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1166−52−5 : Dodecyl gallate Agonist: 0 Antagonist: 0.091

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 116714−46−6 : Novaluron Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 116714−46−6 : Novaluron Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 117−08−8 : Tetrachlorophthalic anhydride Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 117−08−8 : Tetrachlorophthalic anhydride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 117337−19−6 : Fluthiacet−methyl Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 117337−19−6 : Fluthiacet−methyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 117−39−5 : Quercetin Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 117−39−5 : Quercetin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 117428−22−5 : Picoxystrobin Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 117428−22−5 : Picoxystrobin Agonist: 0 Antagonist: 0.00049

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 117718−60−2 : Thiazopyr Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 117718−60−2 : Thiazopyr Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 117−79−3 : 2−Aminoanthraquinone Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 117−79−3 : 2−Aminoanthraquinone Agonist: 0.01 Antagonist: 0.015

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 117−80−6 : Dichlone Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 117−80−6 : Dichlone Agonist: 0 Antagonist: 0.00047

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 117−81−7 : Di(2−ethylhexyl) phthalate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 117−81−7 : Di(2−ethylhexyl) phthalate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 117−84−0 : Dioctyl phthalate Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 117−84−0 : Dioctyl phthalate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 117−99−7 : 2−Hydroxybenzophenone Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 117−99−7 : 2−Hydroxybenzophenone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 118134−30−8 : Spiroxamine Chemical QC [ ? P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 118134−30−8 : Spiroxamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 118−47−8 : 1H−Pyrazole−3−carboxylic acid, 4,5−dihydro−5−oxo−1−(4−sulfophenyl)− Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 118−47−8 : 1H−Pyrazole−3−carboxylic acid, 4,5−dihydro−5−oxo−1−(4−sulfophenyl)− Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 118−52−5 : 1,3−Dichloro−5,5−dimethylhydantoin Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 118−52−5 : 1,3−Dichloro−5,5−dimethylhydantoin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 118−55−8 : Phenyl salicylate Chemical QC [ N.D. N.D. N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 118−55−8 : Phenyl salicylate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 118−56−9 : 3,3,5−Trimethylcyclohexyl salicylate Chemical QC [ N.D. N.D. N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 118−56−9 : 3,3,5−Trimethylcyclohexyl salicylate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 118−58−1 : Benzyl salicylate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 118−58−1 : Benzyl salicylate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 118−71−8 : Maltol Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 118−71−8 : Maltol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 118−79−6 : 2,4,6−Tribromophenol Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 118−79−6 : 2,4,6−Tribromophenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 118−82−1 : 4,4'−Methylenebis(2,6−di−t−butylphenol) Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 118−82−1 : 4,4'−Methylenebis(2,6−di−t−butylphenol) Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1189−08−8 : 1,3−Butyleneglycol dimethacrylate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1189−08−8 : 1,3−Butyleneglycol dimethacrylate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 118−93−4 : 2−Hydroxyacetophenone Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 118−93−4 : 2−Hydroxyacetophenone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 119−07−3 : Octyl decyl phthalate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 119−07−3 : Octyl decyl phthalate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1191−50−0 : Sodium myristyl sulfate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1191−50−0 : Sodium myristyl sulfate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 119168−77−3 : Tebufenpyrad Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 119168−77−3 : Tebufenpyrad Agonist: 0 Antagonist: 0.00077

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1191914−21−2 : PharmaGSID_48521 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1191914−21−2 : PharmaGSID_48521 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1192−52−5 : 4,5−Dichloro−3H−1,2−dithiol−3−one Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1192−52−5 : 4,5−Dichloro−3H−1,2−dithiol−3−one Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 119−36−8 : Methyl salicylate Chemical QC [ ? N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 119−36−8 : Methyl salicylate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 119446−68−3 : Difenoconazole Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 119446−68−3 : Difenoconazole Agonist: 0 Antagonist: 0.13

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1194−65−6 : Dichlobenil Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1194−65−6 : Dichlobenil Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 119−47−1 : 2,2'−Methylenebis(4−methyl−6−tert−butylphenol) Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 119−47−1 : 2,2'−Methylenebis(4−methyl−6−tert−butylphenol) Agonist: 0 Antagonist: 0.00012

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 119515−38−7 : Icaridin Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 119515−38−7 : Icaridin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 119−53−9 : Benzoin Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 119−53−9 : Benzoin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 119−61−9 : Benzophenone Chemical QC [ N.D. N.D. N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 119−61−9 : Benzophenone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 119−64−2 : Tetralin Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 119−64−2 : Tetralin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 119−90−4 : 3,3'−Dimethoxybenzidine Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 119−90−4 : 3,3'−Dimethoxybenzidine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 119−93−7 : 3,3'−Dimethylbenzidine Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 119−93−7 : 3,3'−Dimethylbenzidine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120068−37−3 : Fipronil Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120068−37−3 : Fipronil Agonist: 0 Antagonist: 0.052

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120116−88−3 : Cyazofamid Chemical QC [ ? ? P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120116−88−3 : Cyazofamid Agonist: 0 Antagonist: 0.033

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−12−7 : Anthracene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−12−7 : Anthracene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−14−9 : Veratraldehyde Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−14−9 : Veratraldehyde Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−18−3 : Naphthalene−2−sulfonic acid Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−18−3 : Naphthalene−2−sulfonic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−32−1 : Clorophene Chemical QC [ N.D. P P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−32−1 : Clorophene Agonist: 0 Antagonist: 0.13

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−36−5 : Dichlorprop Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−36−5 : Dichlorprop Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−46−7 : 1,3−Diphenyl−1,3−propanedione Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−46−7 : 1,3−Diphenyl−1,3−propanedione Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−47−8 : Ethylparaben Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−47−8 : Ethylparaben Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120511−73−1 : Anastrozole Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120511−73−1 : Anastrozole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−51−4 : Benzyl benzoate Chemical QC [ N.D. N.D. N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−51−4 : Benzyl benzoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−55−8 : Diethylene glycol dibenzoate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−55−8 : Diethylene glycol dibenzoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−56−9 : Triethylene glycol dibenzoate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−56−9 : Triethylene glycol dibenzoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−61−6 : Dimethyl terephthalate Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−61−6 : Dimethyl terephthalate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−65−0 : 2−((Dimethylamino)methyl)phenol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−65−0 : 2−((Dimethylamino)methyl)phenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−71−8 : 2−Methoxy−5−methylaniline Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−71−8 : 2−Methoxy−5−methylaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−72−9 : Indole Chemical QC [ N.D. N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−72−9 : Indole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−80−9 : Catechol Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−80−9 : Catechol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−82−1 : 1,2,4−Trichlorobenzene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−82−1 : 1,2,4−Trichlorobenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−83−2 : 2,4−Dichlorophenol Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−83−2 : 2,4−Dichlorophenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−92−3 : Cyclopentanone Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−92−3 : Cyclopentanone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−95−6 : 2,4−Bis(2−methylbutan−2−yl)phenol Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 120−95−6 : 2,4−Bis(2−methylbutan−2−yl)phenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 121−00−6 : 2−tert−Butyl−4−methoxyphenol Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 121−00−6 : 2−tert−Butyl−4−methoxyphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 12108−13−3 : Manganese, tricarbonyl[(1,2,3,4,5−.eta.)−1−methyl−2,4−cyclopentadien−1−yl]− Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 12108−13−3 : Manganese, tricarbonyl[(1,2,3,4,5−.eta.)−1−methyl−2,4−cyclopentadien−1−yl]− Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 121−14−2 : 2,4−Dinitrotoluene Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 121−14−2 : 2,4−Dinitrotoluene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 121−32−4 : 3−Ethoxy−4−hydroxybenzaldehyde Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 121−32−4 : 3−Ethoxy−4−hydroxybenzaldehyde Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 121−33−5 : 4−Hydroxy−3−methoxybenzaldehyde Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 121−33−5 : 4−Hydroxy−3−methoxybenzaldehyde Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 121−39−1 : Ethyl 3−phenylglycidate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 121−39−1 : Ethyl 3−phenylglycidate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1214−39−7 : N−Benzyladenine Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1214−39−7 : N−Benzyladenine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 121552−61−2 : Cyprodinil Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 121552−61−2 : Cyprodinil Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 121−69−7 : N,N−Dimethylaniline Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 121−69−7 : N,N−Dimethylaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 121−75−5 : Malathion Chemical QC [ ? ? N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 121−75−5 : Malathion Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 121−79−9 : Propyl gallate Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 121−79−9 : Propyl gallate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 121−91−5 : 1,3−Benzenedicarboxylic acid Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 121−91−5 : 1,3−Benzenedicarboxylic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1219−38−1 : Octylparaben Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1219−38−1 : Octylparaben Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122008−85−9 : Cyhalofop−butyl Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122008−85−9 : Cyhalofop−butyl Agonist: 0 Antagonist: 0.038

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122−14−5 : Fenitrothion Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122−14−5 : Fenitrothion Agonist: 0.0087 Antagonist: 0.21

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122−20−3 : Triisopropanolamine Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122−20−3 : Triisopropanolamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122−34−9 : Simazine Chemical QC [ N.D. P P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122−34−9 : Simazine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122−39−4 : Diphenylamine Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122−39−4 : Diphenylamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122−40−7 : Pentylcinnamaldehyde Chemical QC [ N.D. N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122−40−7 : Pentylcinnamaldehyde Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122−42−9 : Propham Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122−42−9 : Propham Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122453−73−0 : Chlorfenapyr Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122453−73−0 : Chlorfenapyr Agonist: 0 Antagonist: 0.00028

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122−51−0 : Ethyl orthoformate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122−51−0 : Ethyl orthoformate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122−57−6 : Methyl styryl ketone Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122−57−6 : Methyl styryl ketone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122−62−3 : Bis(2−ethylhexyl) decanedioate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122−62−3 : Bis(2−ethylhexyl) decanedioate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122−66−7 : 1,2−Diphenylhydrazine Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122−66−7 : 1,2−Diphenylhydrazine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122−78−1 : Phenylacetaldehyde Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122−78−1 : Phenylacetaldehyde Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122836−35−5 : Sulfentrazone Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122836−35−5 : Sulfentrazone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122−88−3 : 4−Chlorophenoxyacetic acid Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122−88−3 : 4−Chlorophenoxyacetic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122−99−6 : 2−Phenoxyethanol Chemical QC [ N.D. N.D. N.D. N.D. N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 122−99−6 : 2−Phenoxyethanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−00−2 : 4−Morpholinepropanamine Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−00−2 : 4−Morpholinepropanamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−01−3 : Dodecylbenzene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−01−3 : Dodecylbenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−05−7 : 2−Ethylhexanal Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−05−7 : 2−Ethylhexanal Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−07−9 : 4−Ethylphenol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−07−9 : 4−Ethylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−11−5 : 4−Methoxybenzaldehyde Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−11−5 : 4−Methoxybenzaldehyde Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123122−55−4 : Candoxatril Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123122−55−4 : Candoxatril Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−17−1 : 2,6,8−Trimethyl−4−nonanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−17−1 : 2,6,8−Trimethyl−4−nonanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−25−1 : Diethyl butanedioate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−25−1 : Diethyl butanedioate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123312−89−0 : Pymetrozine Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123312−89−0 : Pymetrozine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−31−9 : Hydroquinone Chemical QC [ N.D. N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−31−9 : Hydroquinone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−33−1 : Maleic hydrazide Chemical QC [ N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−33−1 : Maleic hydrazide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123343−16−8 : Pyrithiobac−sodium Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123343−16−8 : Pyrithiobac−sodium Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−35−3 : Myrcene Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−35−3 : Myrcene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−42−2 : Diacetone alcohol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−42−2 : Diacetone alcohol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−51−3 : Isopentyl alcohol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−51−3 : Isopentyl alcohol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−66−0 : Ethyl hexanoate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−66−0 : Ethyl hexanoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−77−3 : Azodicarbonamide Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−77−3 : Azodicarbonamide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−92−2 : 3−Methylbutyl acetate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−92−2 : 3−Methylbutyl acetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−96−6 : 2−Octanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−96−6 : 2−Octanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−99−9 : Nonanedioic acid Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 123−99−9 : Nonanedioic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 124−04−9 : Hexanedioic acid Chemical QC [ N.D. N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 124−04−9 : Hexanedioic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 124−07−2 : Octanoic acid Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 124−07−2 : Octanoic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 124−09−4 : 1,6−Hexanediamine Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 124−09−4 : 1,6−Hexanediamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 124−13−0 : Octanal Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 124−13−0 : Octanal Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 124−18−5 : Decane Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 124−18−5 : Decane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1241−94−7 : 2−Ethylhexyl diphenyl phosphate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1241−94−7 : 2−Ethylhexyl diphenyl phosphate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 124−19−6 : Nonanal Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 124−19−6 : Nonanal Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 124−22−1 : 1−Dodecanamine Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 124−22−1 : 1−Dodecanamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 12427−38−2 : Maneb Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 12427−38−2 : Maneb Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 124378−77−4 : Enadoline Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 124378−77−4 : Enadoline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 124−40−3 : Dimethylamine Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 124−40−3 : Dimethylamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 124495−18−7 : Quinoxyfen Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 124495−18−7 : Quinoxyfen Agonist: 0 Antagonist: 0.022

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 124−68−5 : 2−Amino−2−methylpropan−1−ol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 124−68−5 : 2−Amino−2−methylpropan−1−ol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 124−76−5 : Isoborneol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 124−76−5 : Isoborneol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 124−94−7 : Triamcinolone Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 124−94−7 : Triamcinolone Agonist: 0.15 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 125116−23−6 : Metconazole Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 125116−23−6 : Metconazole Agonist: 0.0026 Antagonist: 0.15

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 125−12−2 : Isobornyl acetate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 125−12−2 : Isobornyl acetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 125225−28−7 : Ipconazole Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 125225−28−7 : Ipconazole Agonist: 0 Antagonist: 0.16

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 125401−92−5 : Bispyribac−sodium Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 125401−92−5 : Bispyribac−sodium Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 125−84−8 : Aminoglutethimide Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 125−84−8 : Aminoglutethimide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 126−00−1 : Diphenolic acid Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 126−00−1 : Diphenolic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1260−17−9 : Carminic acid Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1260−17−9 : Carminic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 126−06−7 : 3−Bromo−1−chloro−5,5−dimethylhydantoin Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 126−06−7 : 3−Bromo−1−chloro−5,5−dimethylhydantoin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 126−11−4 : 2−(Hydroxymethyl)−2−nitro−1,3−propanediol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 126−11−4 : 2−(Hydroxymethyl)−2−nitro−1,3−propanediol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 126−14−7 : Sucrose octaacetate Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 126−14−7 : Sucrose octaacetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 126−30−7 : 2,2−Dimethylpropane−1,3−diol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 126−30−7 : 2,2−Dimethylpropane−1,3−diol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 126−72−7 : Tris(2,3−dibromopropyl) phosphate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 126−72−7 : Tris(2,3−dibromopropyl) phosphate Agonist: 0 Antagonist: 0.024

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 126−73−8 : Tributyl phosphate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 126−73−8 : Tributyl phosphate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 126833−17−8 : Fenhexamid Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 126833−17−8 : Fenhexamid Agonist: 0 Antagonist: 0.054

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 126−86−3 : 2,4,7,9−Tetramethyl−5−decyne−4,7−diol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 126−86−3 : 2,4,7,9−Tetramethyl−5−decyne−4,7−diol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 126−92−1 : Sodium ethasulfate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 126−92−1 : Sodium ethasulfate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 126−98−7 : Methacrylonitrile Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 126−98−7 : Methacrylonitrile Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 127−07−1 : Hydroxyurea Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 127−07−1 : Hydroxyurea Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 127−19−5 : N,N−Dimethylacetamide Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 127−19−5 : N,N−Dimethylacetamide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 127−25−3 : Methyl abietate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 127−25−3 : Methyl abietate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 127308−82−1 : Zamifenacin Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 127308−82−1 : Zamifenacin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 127−39−9 : Sodium 1,4−diisobutyl sulfosuccinate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 127−39−9 : Sodium 1,4−diisobutyl sulfosuccinate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 127−41−3 : alpha−Ionone Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 127−41−3 : alpha−Ionone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 127−47−9 : Retinol acetate Chemical QC [ N.D. N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 127−47−9 : Retinol acetate Agonist: 0 Antagonist: 0.065

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 127−51−5 : alpha−Isomethylionone Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 127−51−5 : alpha−Isomethylionone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 128−04−1 : Sodium dimethyldithiocarbamate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 128−04−1 : Sodium dimethyldithiocarbamate Agonist: 0 Antagonist: 4.5e−05

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 128−37−0 : Butylated hydroxytoluene Chemical QC [ N.D. N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 128−37−0 : Butylated hydroxytoluene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 128−39−2 : 2,6−Di−tert−butylphenol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 128−39−2 : 2,6−Di−tert−butylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 128639−02−1 : Carfentrazone−ethyl Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 128639−02−1 : Carfentrazone−ethyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 128−95−0 : 1,4−Diaminoanthraquinone Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 128−95−0 : 1,4−Diaminoanthraquinone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 129−00−0 : Pyrene Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 129−00−0 : Pyrene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 129−06−6 : Sodium warfarin Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 129−06−6 : Sodium warfarin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 129−17−9 : Sulfan blue Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 129−17−9 : Sulfan blue Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 129298−91−5 : TNP−470 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 129298−91−5 : TNP−470 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 129299−90−7 : Fabesetron hydrochloride Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 129299−90−7 : Fabesetron hydrochloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 129453−61−8 : Fulvestrant Chemical QC [ ? ? N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 129453−61−8 : Fulvestrant Agonist: 0 Antagonist: 0.089

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 129630−19−9 : Pyraflufen−ethyl Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 129630−19−9 : Pyraflufen−ethyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1300−72−7 : Sodium xylenesulfonate Chemical QC [ ? P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1300−72−7 : Sodium xylenesulfonate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1300−73−8 : Dimethylaniline Chemical QC [ ? ? ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1300−73−8 : Dimethylaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 130−14−3 : Sodium 1−naphthalenesulfonate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 130−14−3 : Sodium 1−naphthalenesulfonate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1303−11−3 : Indium arsenide Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1303−11−3 : Indium arsenide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13071−79−9 : Terbufos Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13071−79−9 : Terbufos Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 131−11−3 : Dimethyl phthalate Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 131−11−3 : Dimethyl phthalate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 131−17−9 : Diallyl phthalate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 131−17−9 : Diallyl phthalate Agonist: 1.5e−05 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 131−18−0 : Dipentyl phthalate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 131−18−0 : Dipentyl phthalate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 131341−86−1 : Fludioxonil Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 131341−86−1 : Fludioxonil Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 131−55−5 : 2,2',4,4'−Tetrahydroxybenzophenone Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 131−55−5 : 2,2',4,4'−Tetrahydroxybenzophenone Agonist: 0.064 Antagonist: 0.096

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 131−56−6 : 2,4−Dihydroxybenzophenone Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 131−56−6 : 2,4−Dihydroxybenzophenone Agonist: 0 Antagonist: 0.058

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 131−57−7 : 2−Hydroxy−4−methoxybenzophenone Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 131−57−7 : 2−Hydroxy−4−methoxybenzophenone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 131−70−4 : Monobutyl phthalate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 131−70−4 : Monobutyl phthalate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13171−00−1 : 1−(6−tert−Butyl−1,1−dimethyl−2,3−dihydro−1H−inden−4−yl)ethanone Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13171−00−1 : 1−(6−tert−Butyl−1,1−dimethyl−2,3−dihydro−1H−inden−4−yl)ethanone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 131807−57−3 : Famoxadone Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 131807−57−3 : Famoxadone Agonist: 0 Antagonist: 0.00036

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 131860−33−8 : Azoxystrobin Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 131860−33−8 : Azoxystrobin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13194−48−4 : Ethoprop Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13194−48−4 : Ethoprop Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 131983−72−7 : Triticonazole Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 131983−72−7 : Triticonazole Agonist: 0.16 Antagonist: 0.1

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1320−07−6 : C.I. Acid Orange 24, monosodium salt Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1320−07−6 : C.I. Acid Orange 24, monosodium salt Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1321−74−0 : Divinylbenzene Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1321−74−0 : Divinylbenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1323−19−9 : Sodium 2,4,7−tri(propan−2−yl)naphthalene−1−sulfonate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1323−19−9 : Sodium 2,4,7−tri(propan−2−yl)naphthalene−1−sulfonate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1323−38−2 : Glyceryl monoricinoleate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1323−38−2 : Glyceryl monoricinoleate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13254−34−7 : 2,6−Dimethyl−2−heptanol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13254−34−7 : 2,6−Dimethyl−2−heptanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 132−64−9 : Dibenzofuran Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 132−64−9 : Dibenzofuran Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 132−65−0 : Dibenzothiophene Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 132−65−0 : Dibenzothiophene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13292−46−1 : Rifampicin Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13292−46−1 : Rifampicin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13301−61−6 : C.I. Disperse Orange 37 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13301−61−6 : C.I. Disperse Orange 37 Agonist: 0.0086 Antagonist: 0.013

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 133−06−2 : Captan Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 133−06−2 : Captan Agonist: 0 Antagonist: 0.15

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 133−07−3 : Folpet Chemical QC [ N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 133−07−3 : Folpet Agonist: 0 Antagonist: 0.12

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1330−78−5 : Tricresyl phosphate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1330−78−5 : Tricresyl phosphate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1330−86−5 : Diisooctyl adipate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1330−86−5 : Diisooctyl adipate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13311−84−7 : Flutamide Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13311−84−7 : Flutamide Agonist: 0 Antagonist: 0.23

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1333−39−7 : Phenolsulfonic acid Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1333−39−7 : Phenolsulfonic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1335−46−2 : Ionone, methyl− Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1335−46−2 : Ionone, methyl− Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1338−43−8 : Sorbitan, mono−(9Z)−9−octadecenoate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1338−43−8 : Sorbitan, mono−(9Z)−9−octadecenoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 133855−98−8 : Epoxiconazole Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 133855−98−8 : Epoxiconazole Agonist: 0 Antagonist: 0.012

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 133−90−4 : Chloramben Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 133−90−4 : Chloramben Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 134002−60−1 : CP−085958 Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 134002−60−1 : CP−085958 Agonist: 0.008 Antagonist: 0.012

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 134−03−2 : Sodium L−ascorbate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 134−03−2 : Sodium L−ascorbate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 134−20−3 : Methyl 2−aminobenzoate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 134−20−3 : Methyl 2−aminobenzoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 134−31−6 : 8−Hydroxyquinoline sulfate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 134−31−6 : 8−Hydroxyquinoline sulfate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 134523−03−8 : Atorvastatin calcium Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 134523−03−8 : Atorvastatin calcium Agonist: 0 Antagonist: 0.02

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 134605−64−4 : Butafenacil Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 134605−64−4 : Butafenacil Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 134−62−3 : DEET Chemical QC [ N.D. P P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 134−62−3 : DEET Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13463−41−7 : Zinc pyrithione Chemical QC [ N.D. N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13463−41−7 : Zinc pyrithione Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 135080−03−4 : CP−100829 Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 135080−03−4 : CP−100829 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 135158−54−2 : Acibenzolar−S−methyl Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 135158−54−2 : Acibenzolar−S−methyl Agonist: 0.032 Antagonist: 0.048

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 135−19−3 : 2−Naphthalenol Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 135−19−3 : 2−Naphthalenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 135−20−6 : Cupferron Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 135−20−6 : Cupferron Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 135410−20−7 : Acetamiprid Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 135410−20−7 : Acetamiprid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 136042−19−8 : FR130739 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 136042−19−8 : FR130739 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 136−45−8 : Dipropyl pyridine−2,5−dicarboxylate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 136−45−8 : Dipropyl pyridine−2,5−dicarboxylate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 136−60−7 : Butyl benzoate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 136−60−7 : Butyl benzoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13674−84−5 : Tris(2−chloroisopropyl)phosphate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13674−84−5 : Tris(2−chloroisopropyl)phosphate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13674−87−8 : Tris(1,3−dichloro−2−propyl)phosphate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13674−87−8 : Tris(1,3−dichloro−2−propyl)phosphate Agonist: 0 Antagonist: 0.13

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 136−77−6 : 4−Hexylresorcinol Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 136−77−6 : 4−Hexylresorcinol Agonist: 0 Antagonist: 0.046

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13680−35−8 : 4,4'−Methylenebis(2,6−diethylaniline) Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13680−35−8 : 4,4'−Methylenebis(2,6−diethylaniline) Agonist: 0 Antagonist: 0.05

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13684−56−5 : Desmedipham Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13684−56−5 : Desmedipham Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13684−63−4 : Phenmedipham Chemical QC [ ? ? ? ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13684−63−4 : Phenmedipham Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 137−26−8 : Thiram Chemical QC [ N.D. P P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 137−26−8 : Thiram Agonist: 0 Antagonist: 0.049

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 137−30−4 : Ziram Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 137−30−4 : Ziram Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 137−42−8 : Metam−sodium Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 137−42−8 : Metam−sodium Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13755−29−8 : Sodium tetrafluoroborate Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13755−29−8 : Sodium tetrafluoroborate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 137−66−6 : Ascorbyl palmitate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 137−66−6 : Ascorbyl palmitate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 138−22−7 : Butyl lactate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 138−22−7 : Butyl lactate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 138261−41−3 : Imidacloprid Chemical QC [ N.D. P P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 138261−41−3 : Imidacloprid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13826−35−2 : 3−Phenoxybenzenemethanol Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 13826−35−2 : 3−Phenoxybenzenemethanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 138472−01−2 : FR900409 Chemical QC [ ? ? ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 138472−01−2 : FR900409 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 138−86−3 : Limonene Chemical QC [ ? N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 138−86−3 : Limonene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 139−02−6 : Sodium phenolate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 139−02−6 : Sodium phenolate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 139−13−9 : Nitrilotriacetic acid Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 139−13−9 : Nitrilotriacetic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 139149−55−6 : SB202235 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 139149−55−6 : SB202235 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 139290−65−6 : Volinanserin Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 139290−65−6 : Volinanserin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 139340−56−0 : Darbufelone mesylate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 139340−56−0 : Darbufelone mesylate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 139−40−2 : Propazine Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 139−40−2 : Propazine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 139−87−7 : Ethyl diethanolamine Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 139−87−7 : Ethyl diethanolamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 139−88−8 : 7−Ethyl−2−methyl−4−undecanolsulfate, sodium salt Chemical QC [ ? N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 139−88−8 : 7−Ethyl−2−methyl−4−undecanolsulfate, sodium salt Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 139−96−8 : Dodecyl sulfate triethanolamine Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 139−96−8 : Dodecyl sulfate triethanolamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 140−08−9 : Tris(2−chloroethyl) phosphite Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 140−08−9 : Tris(2−chloroethyl) phosphite Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 140−10−3 : Cinnamic acid Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 140−10−3 : Cinnamic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 140−11−4 : Benzyl acetate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 140−11−4 : Benzyl acetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1401−55−4 : Tannic acid Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1401−55−4 : Tannic acid Agonist: 0 Antagonist: 0.13

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 140−31−8 : 1−(2−Aminoethyl)piperazine Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 140−31−8 : 1−(2−Aminoethyl)piperazine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 140−38−5 : 4−Chlorophenylurea Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 140−38−5 : 4−Chlorophenylurea Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 140−56−7 : Fenaminosulf Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 140−56−7 : Fenaminosulf Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 140−64−7 : Pentamidine isethionate Chemical QC [ N.D. N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 140−64−7 : Pentamidine isethionate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 140−66−9 : 4−(1,1,3,3−Tetramethylbutyl)phenol Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 140−66−9 : 4−(1,1,3,3−Tetramethylbutyl)phenol Agonist: 0.024 Antagonist: 0.036

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 140−67−0 : Estragole Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 140−67−0 : Estragole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 140−95−4 : Dimethylolurea Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 140−95−4 : Dimethylolurea Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 141−04−8 : Diisobutyl adipate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 141−04−8 : Diisobutyl adipate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 141112−29−0 : Isoxaflutole Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 141112−29−0 : Isoxaflutole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 141−22−0 : 9−Octadecenoic acid, 12−hydroxy−, (9Z,12R)− Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 141−22−0 : 9−Octadecenoic acid, 12−hydroxy−, (9Z,12R)− Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 141−32−2 : Butyl acrylate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 141−32−2 : Butyl acrylate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 141−43−5 : Ethanolamine Chemical QC [ P−MW P−MW ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 141−43−5 : Ethanolamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 141517−21−7 : Trifloxystrobin Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 141517−21−7 : Trifloxystrobin Agonist: 0 Antagonist: 0.00043

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 141−66−2 : Dicrotophos Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 141−66−2 : Dicrotophos Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 141−79−7 : 4−Methylpent−3−en−2−one Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 141−79−7 : 4−Methylpent−3−en−2−one Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 142−04−1 : Aniline hydrochloride Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 142−04−1 : Aniline hydrochloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 142−16−5 : Bis(2−ethylhexyl) maleate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 142−16−5 : Bis(2−ethylhexyl) maleate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 142−18−7 : 1−Monolaurin Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 142−18−7 : 1−Monolaurin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 142−31−4 : Sodium octyl sulfate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 142−31−4 : Sodium octyl sulfate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 14233−37−5 : 1,4−Bis(N−isopropylamino)anthraquinone Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 14233−37−5 : 1,4−Bis(N−isopropylamino)anthraquinone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 142459−58−3 : Flufenacet Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 142459−58−3 : Flufenacet Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 142−62−1 : Hexanoic acid Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 142−62−1 : Hexanoic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 142−87−0 : Sodium decyl sulfate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 142−87−0 : Sodium decyl sulfate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 143−07−7 : Dodecanoic acid Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 143−07−7 : Dodecanoic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 143−08−8 : 1−Nonanol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 143−08−8 : 1−Nonanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 143−22−6 : 2−[2−(2−Butoxyethoxy)ethoxy]ethanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 143−22−6 : 2−[2−(2−Butoxyethoxy)ethoxy]ethanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 143390−89−0 : Kresoxim−methyl Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 143390−89−0 : Kresoxim−methyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1434−54−4 : Pregnenolone carbonitrile Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1434−54−4 : Pregnenolone carbonitrile Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 143−50−0 : Kepone Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 143−50−0 : Kepone Agonist: 0 Antagonist: 0.094

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 14351−66−7 : Sodium abietate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 14351−66−7 : Sodium abietate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 14371−10−9 : (2E)−3−Phenylprop−2−enal Chemical QC [ ? ? N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 14371−10−9 : (2E)−3−Phenylprop−2−enal Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 143−74−8 : Phenol red Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 143−74−8 : Phenol red Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 144−49−0 : Fluoroacetic acid Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 144−49−0 : Fluoroacetic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 144550−36−7 : Iodosulfuron−methyl−sodium Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 144550−36−7 : Iodosulfuron−methyl−sodium Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1445−75−6 : Diisopropyl methylphosphonate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1445−75−6 : Diisopropyl methylphosphonate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 144−62−7 : Oxalic acid Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 144−62−7 : Oxalic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 145701−21−9 : Diclosulam Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 145701−21−9 : Diclosulam Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 145−73−3 : Endothal Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 145−73−3 : Endothal Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 145742−28−5 : CP−122721 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 145742−28−5 : CP−122721 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1459−93−4 : Dimethyl isophthalate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1459−93−4 : Dimethyl isophthalate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 146011−65−6 : FR145237 Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 146011−65−6 : FR145237 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1461−22−9 : Tributyltin chloride Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1461−22−9 : Tributyltin chloride Agonist: 0.0034 Antagonist: 0.15

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1461−25−2 : Tetrabutyltin Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1461−25−2 : Tetrabutyltin Agonist: 0 Antagonist: 6.3e−05

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 147−24−0 : Diphenhydramine hydrochloride Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 147−24−0 : Diphenhydramine hydrochloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 14765−30−1 : 2−sec−Butylcyclohexanone Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 14765−30−1 : 2−sec−Butylcyclohexanone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1477−55−0 : 1,3−Benzenedimethanamine Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1477−55−0 : 1,3−Benzenedimethanamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 147−81−9 : Arabinose Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 147−81−9 : Arabinose Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1478−61−1 : Bisphenol AF Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1478−61−1 : Bisphenol AF Agonist: 0.00075 Antagonist: 0.16

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 14816−18−3 : Phoxim Chemical QC [ N.D. P P P−MW ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 14816−18−3 : Phoxim Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 148−24−3 : 8−Hydroxyquinoline Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 148−24−3 : 8−Hydroxyquinoline Agonist: 0 Antagonist: 0.00039

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 148477−71−8 : Spirodiclofen Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 148477−71−8 : Spirodiclofen Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 148−79−8 : Thiabendazole Chemical QC [ N.D. P P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 148−79−8 : Thiabendazole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1490−04−6 : Menthol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1490−04−6 : Menthol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 14901−07−6 : 4−(2,6,6−Trimethyl−cyclohex−1−enyl)−but−3−en−2−one Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 14901−07−6 : 4−(2,6,6−Trimethyl−cyclohex−1−enyl)−but−3−en−2−one Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 149062−75−9 : PharmaGSID_47259 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 149062−75−9 : PharmaGSID_47259 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 149−30−4 : 2−Mercaptobenzothiazole Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 149−30−4 : 2−Mercaptobenzothiazole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 149413−74−1 : FR150011 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 149413−74−1 : FR150011 Agonist: 0 Antagonist: 0.072

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 149−57−5 : 2−Ethylhexanoic acid Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 149−57−5 : 2−Ethylhexanoic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 149877−41−8 : Bifenazate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 149877−41−8 : Bifenazate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 149979−41−9 : Tepraloxydim Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 149979−41−9 : Tepraloxydim Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 150−13−0 : 4−Aminobenzoic acid Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 150−13−0 : 4−Aminobenzoic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 15046−75−0 : Sodium 2−methylbenzenesulfonate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 15046−75−0 : Sodium 2−methylbenzenesulfonate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 150−68−5 : Monuron Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 150−68−5 : Monuron Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 150−76−5 : 4−Methoxyphenol Chemical QC [ N.D. N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 150−76−5 : 4−Methoxyphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 150−78−7 : Hydroquinone dimethyl ether Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 150−78−7 : Hydroquinone dimethyl ether Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 151−05−3 : Dimethylbenzylcarbinyl acetate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 151−05−3 : Dimethylbenzylcarbinyl acetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 151−21−3 : Sodium dodecyl sulfate Chemical QC [ N.D. N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 151−21−3 : Sodium dodecyl sulfate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 151506−44−4 : FR140423 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 151506−44−4 : FR140423 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 15214−89−8 : 2−Acrylamido−2−methyl−1−propanesulfonic acid Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 15214−89−8 : 2−Acrylamido−2−methyl−1−propanesulfonic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 15299−99−7 : Napropamide Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 15299−99−7 : Napropamide Agonist: 0 Antagonist: 0.12

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 15307−79−6 : Diclofenac sodium Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 15307−79−6 : Diclofenac sodium Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 15310−01−7 : Benodanil Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 15310−01−7 : Benodanil Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 153233−91−1 : Etoxazole Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 153233−91−1 : Etoxazole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 153719−23−4 : Thiamethoxam Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 153719−23−4 : Thiamethoxam Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1541−81−7 : 4−Dodecylmorpholine Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1541−81−7 : 4−Dodecylmorpholine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 154−42−7 : 6−Thioguanine Chemical QC [ N.D. P P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 154−42−7 : 6−Thioguanine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 15499−27−1 : 4−Butylchlorobenzene Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 15499−27−1 : 4−Butylchlorobenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 155569−91−8 : Emamectin benzoate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 155569−91−8 : Emamectin benzoate Agonist: 0 Antagonist: 0.19

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1559−34−8 : 3,6,9,12−Tetraoxahexadecan−1−ol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1559−34−8 : 3,6,9,12−Tetraoxahexadecan−1−ol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1559−35−9 : 2−(2−Ethylhexyloxy)ethanol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1559−35−9 : 2−(2−Ethylhexyloxy)ethanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 155990−20−8 : SR271425 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 155990−20−8 : SR271425 Agonist: 0.089 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 156052−68−5 : Zoxamide Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 156052−68−5 : Zoxamide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 156−10−5 : 4−Nitrosodiphenylamine Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 156−10−5 : 4−Nitrosodiphenylamine Agonist: 0 Antagonist: 0.035

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 15619−48−4 : 1−Benzylquinolinium chloride Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 15619−48−4 : 1−Benzylquinolinium chloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1563−38−8 : 2,3−Dihydro−2,2−dimethyl−7−benzofuranol Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1563−38−8 : 2,3−Dihydro−2,2−dimethyl−7−benzofuranol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1563−66−2 : Carbofuran Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1563−66−2 : Carbofuran Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 156−43−4 : 4−Ethoxyaniline Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 156−43−4 : 4−Ethoxyaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 156−60−5 : (E)−1,2−Dichloroethylene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 156−60−5 : (E)−1,2−Dichloroethylene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1569−01−3 : 1−Propoxy−2−propanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1569−01−3 : 1−Propoxy−2−propanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1569−02−4 : 1−Ethoxy−2−propanol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1569−02−4 : 1−Ethoxy−2−propanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1570−64−5 : 4−Chloro−2−methylphenol Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1570−64−5 : 4−Chloro−2−methylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 15708−41−5 : Ethylenediaminetetraacetic acid ferric sodium salt Chemical QC [ N.D. N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 15708−41−5 : Ethylenediaminetetraacetic acid ferric sodium salt Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 158081−99−3 : CP−105696 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 158081−99−3 : CP−105696 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1582−09−8 : Trifluralin Chemical QC [ N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1582−09−8 : Trifluralin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 159138−81−5 : Cariporide mesylate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 159138−81−5 : Cariporide mesylate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1596−84−5 : Daminozide Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1596−84−5 : Daminozide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 15972−60−8 : Alachlor Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 15972−60−8 : Alachlor Agonist: 0 Antagonist: 0.092

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 16079−88−2 : Bromo−3−chloro−5,5−dimethylhydantoin Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 16079−88−2 : Bromo−3−chloro−5,5−dimethylhydantoin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1610−18−0 : Prometon Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1610−18−0 : Prometon Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 161050−58−4 : Methoxyfenozide Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 161050−58−4 : Methoxyfenozide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 161326−34−7 : Fenamidone Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 161326−34−7 : Fenamidone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 16219−75−3 : 5−Ethylidene−2−norbornene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 16219−75−3 : 5−Ethylidene−2−norbornene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1625−91−8 : 4,4'−Di−tert−butylbiphenyl Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1625−91−8 : 4,4'−Di−tert−butylbiphenyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 162706−14−1 : UK−156819 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 162706−14−1 : UK−156819 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1632−73−1 : Fenchol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1632−73−1 : Fenchol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1634−78−2 : Malaoxon Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1634−78−2 : Malaoxon Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 163520−33−0 : Isoxadifen−ethyl Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 163520−33−0 : Isoxadifen−ethyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1638−22−8 : 4−Butylphenol Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1638−22−8 : 4−Butylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 16423−68−0 : FD&C Red 3 Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 16423−68−0 : FD&C Red 3 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1646−75−9 : Aldicarb oxime Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1646−75−9 : Aldicarb oxime Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1646−87−3 : Aldicarb sulfoxide Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1646−87−3 : Aldicarb sulfoxide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1646−88−4 : Aldoxycarb Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1646−88−4 : Aldoxycarb Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 165252−70−0 : Dinotefuran Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 165252−70−0 : Dinotefuran Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 16587−71−6 : 4−(tert−Pentyl)−cyclohexanone Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 16587−71−6 : 4−(tert−Pentyl)−cyclohexanone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 166412−78−8 : Diisononyl cyclohexane−1,2−dicarboxylate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 166412−78−8 : Diisononyl cyclohexane−1,2−dicarboxylate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 16672−87−0 : Ethephon Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 16672−87−0 : Ethephon Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1671−75−6 : Heptanophenone Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1671−75−6 : Heptanophenone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 16752−77−5 : Methomyl Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 16752−77−5 : Methomyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1675−54−3 : Bisphenol A diglycidyl ether Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1675−54−3 : Bisphenol A diglycidyl ether Agonist: 0 Antagonist: 0.02

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 16893−85−9 : Sodium hexafluorosilicate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 16893−85−9 : Sodium hexafluorosilicate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1689−84−5 : Bromoxynil Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1689−84−5 : Bromoxynil Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 169590−42−5 : Celecoxib Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 169590−42−5 : Celecoxib Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1698−60−8 : Chloridazon Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1698−60−8 : Chloridazon Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1702−17−6 : Clopyralid Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1702−17−6 : Clopyralid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 171866−31−2 : CP−283097 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 171866−31−2 : CP−283097 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1724−39−6 : Cyclododecanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1724−39−6 : Cyclododecanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 173584−44−6 : Indoxacarb Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 173584−44−6 : Indoxacarb Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 17372−87−1 : Eosin Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 17372−87−1 : Eosin Agonist: 0 Antagonist: 0.11

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 174185−16−1 : FR167356 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 174185−16−1 : FR167356 Agonist: 0 Antagonist: 0.025

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1742−14−9 : 1,1−Bis(3,4−dimethylphenyl)ethane Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1742−14−9 : 1,1−Bis(3,4−dimethylphenyl)ethane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 17465−86−0 : gamma−Cyclodextrin Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 17465−86−0 : gamma−Cyclodextrin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 175013−18−0 : Pyraclostrobin Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 175013−18−0 : Pyraclostrobin Agonist: 0 Antagonist: 0.00035

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1760−24−3 : N−[3−(Trimethoxysilyl)propyl]ethane−1,2−diamine Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1760−24−3 : N−[3−(Trimethoxysilyl)propyl]ethane−1,2−diamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1762−95−4 : Thiocyanic acid, ammonium salt Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1762−95−4 : Thiocyanic acid, ammonium salt Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1763−23−1 : PFOS Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1763−23−1 : PFOS Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 17696−62−7 : Phenylparaben Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 17696−62−7 : Phenylparaben Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 177785−47−6 : PharmaGSID_47261 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 177785−47−6 : PharmaGSID_47261 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 17796−82−6 : N−(Cyclohexylthio)phthalimide Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 17796−82−6 : N−(Cyclohexylthio)phthalimide Agonist: 0 Antagonist: 0.026

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 17804−35−2 : Benomyl Chemical QC [ ? ? N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 17804−35−2 : Benomyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 17924−92−4 : Zearalenone Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 17924−92−4 : Zearalenone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 179465−71−5 : CJ−013790 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 179465−71−5 : CJ−013790 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 180084−01−9 : SB236057A Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 180084−01−9 : SB236057A Agonist: 0 Antagonist: 0.00026

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1806−26−4 : 4−Octylphenol Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1806−26−4 : 4−Octylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 181274−15−7 : Propoxycarbazone−sodium Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 181274−15−7 : Propoxycarbazone−sodium Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 181274−17−9 : Flucarbazone−sodium Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 181274−17−9 : Flucarbazone−sodium Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 181640−09−5 : SR144190 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 181640−09−5 : SR144190 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 18172−67−3 : (−)−beta−Pinene Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 18172−67−3 : (−)−beta−Pinene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1825−21−4 : Pentachloroanisole Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1825−21−4 : Pentachloroanisole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1836−75−5 : Nitrofen Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1836−75−5 : Nitrofen Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1843−05−6 : Octabenzone Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1843−05−6 : Octabenzone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 184653−84−7 : Carabersat Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 184653−84−7 : Carabersat Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1861−32−1 : Chlorthal−dimethyl Chemical QC [ N.D. N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1861−32−1 : Chlorthal−dimethyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1861−40−1 : Benfluralin Chemical QC [ N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1861−40−1 : Benfluralin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 186392−65−4 : Ingliforib Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 186392−65−4 : Ingliforib Agonist: 0 Antagonist: 0.014

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1873−88−7 : 1,1,1,3,5,5,5−Heptamethyltrisiloxane Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1873−88−7 : 1,1,1,3,5,5,5−Heptamethyltrisiloxane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 188425−85−6 : Boscalid Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 188425−85−6 : Boscalid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 188489−07−8 : Flufenpyr−ethyl Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 188489−07−8 : Flufenpyr−ethyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 189003−92−7 : Trelanserin Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 189003−92−7 : Trelanserin Agonist: 0 Antagonist: 0.023

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 18924−66−8 : 2,2'−(Tetradecylimino)diethanol Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 18924−66−8 : 2,2'−(Tetradecylimino)diethanol Agonist: 0 Antagonist: 0.034

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1897−45−6 : Chlorothalonil Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1897−45−6 : Chlorothalonil Agonist: 0 Antagonist: 0.081

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 18979−55−0 : 4−(Hexyloxy)phenol Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 18979−55−0 : 4−(Hexyloxy)phenol Agonist: 0 Antagonist: 8e−05

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 19044−88−3 : Oryzalin Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 19044−88−3 : Oryzalin Agonist: 0 Antagonist: 0.05

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1907−65−9 : N−Butyl−p−toluenesulfonamide Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1907−65−9 : N−Butyl−p−toluenesulfonamide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1912−24−9 : Atrazine Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1912−24−9 : Atrazine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1918−00−9 : Dicamba Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1918−00−9 : Dicamba Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1918−02−1 : Picloram Chemical QC [ P P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1918−02−1 : Picloram Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1918−16−7 : Propachlor Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1918−16−7 : Propachlor Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1929−73−3 : 2,4−D−Butotyl Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1929−73−3 : 2,4−D−Butotyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1929−77−7 : Vernolate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1929−77−7 : Vernolate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1929−82−4 : Nitrapyrin Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1929−82−4 : Nitrapyrin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1934−21−0 : FD&C Yellow 5 Chemical QC [ N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1934−21−0 : FD&C Yellow 5 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1936−15−8 : C.I. Acid Orange 10 Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1936−15−8 : C.I. Acid Orange 10 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 194098−25−4 : CP−409092 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 194098−25−4 : CP−409092 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1948−33−0 : tert−Butylhydroquinone Chemical QC [ P P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1948−33−0 : tert−Butylhydroquinone Agonist: 0 Antagonist: 0.013

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 19666−30−9 : Oxadiazon Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 19666−30−9 : Oxadiazon Agonist: 0 Antagonist: 0.028

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 196808−45−4 : Farglitazar Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 196808−45−4 : Farglitazar Agonist: 0 Antagonist: 0.063

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 197077−55−7 : UK−333747 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 197077−55−7 : UK−333747 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 19774−82−4 : Amiodarone hydrochloride Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 19774−82−4 : Amiodarone hydrochloride Agonist: 0.0025 Antagonist: 0.11

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 19780−11−1 : (2−Dodecenyl)succinic anhydride Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 19780−11−1 : (2−Dodecenyl)succinic anhydride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1987−50−4 : 4−Heptylphenol Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 1987−50−4 : 4−Heptylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 199119−58−9 : Trifloxysulfuron−sodium Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 199119−58−9 : Trifloxysulfuron−sodium Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 199171−88−5 : CP−401387 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 199171−88−5 : CP−401387 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 199584−38−8 : 1−Methoxy−4−tert−pentylcyclohexane Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 199584−38−8 : 1−Methoxy−4−tert−pentylcyclohexane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2008−41−5 : Butylate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2008−41−5 : Butylate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 200940−23−4 : SB243213A Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 200940−23−4 : SB243213A Agonist: 0 Antagonist: 0.036

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2016−57−1 : 1−Decanamine Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2016−57−1 : 1−Decanamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 20265−97−8 : 4−Methoxyaniline hydrochloride Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 20265−97−8 : 4−Methoxyaniline hydrochloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2031−67−6 : Triethoxymethylsilane Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2031−67−6 : Triethoxymethylsilane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 20325−40−0 : 3,3'−Dimethoxybenzidine dihydrochloride Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 20325−40−0 : 3,3'−Dimethoxybenzidine dihydrochloride Agonist: 0 Antagonist: 0.16

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 203942−49−8 : UK−337312 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 203942−49−8 : UK−337312 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2043−57−4 : 1H,1H,2H,2H−Perfluorooctyl iodide Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2043−57−4 : 1H,1H,2H,2H−Perfluorooctyl iodide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2044−64−6 : N,N−Dimethylacetoacetamide Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2044−64−6 : N,N−Dimethylacetoacetamide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2058−46−0 : Oxytetracycline hydrochloride Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2058−46−0 : Oxytetracycline hydrochloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2058−94−8 : Perfluoroundecanoic acid Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2058−94−8 : Perfluoroundecanoic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 205−99−2 : Benzo(b)fluoranthene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 205−99−2 : Benzo(b)fluoranthene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 206−44−0 : Fluoranthene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 206−44−0 : Fluoranthene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 207736−05−8 : CI−1029 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 207736−05−8 : CI−1029 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 20780−48−7 : 3,7−Dimethyloctan−3−yl acetate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 20780−48−7 : 3,7−Dimethyloctan−3−yl acetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2078−54−8 : Propofol Chemical QC [ N.D. N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2078−54−8 : Propofol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 20830−75−5 : Digoxin Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 20830−75−5 : Digoxin Agonist: 0 Antagonist: 0.092

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 208−96−8 : Acenaphthylene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 208−96−8 : Acenaphthylene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2104−64−5 : EPN Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2104−64−5 : EPN Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 210631−68−8 : Topramezone Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 210631−68−8 : Topramezone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 210826−40−7 : CP−456773 Chemical QC [ ? ? ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 210826−40−7 : CP−456773 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 21087−64−9 : Metribuzin Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 21087−64−9 : Metribuzin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 210880−92−5 : Clothianidin Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 210880−92−5 : Clothianidin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2110−18−1 : 2−(3−Phenylpropyl)pyridine Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2110−18−1 : 2−(3−Phenylpropyl)pyridine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 21145−77−7 : 6−Acetyl−1,1,2,4,4,7−hexamethyltetralin Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 21145−77−7 : 6−Acetyl−1,1,2,4,4,7−hexamethyltetralin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2122−70−5 : Ethyl 1−naphthaleneacetate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2122−70−5 : Ethyl 1−naphthaleneacetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 21245−02−3 : 2−Ethylhexyl 4−(dimethylamino)benzoate Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 21245−02−3 : 2−Ethylhexyl 4−(dimethylamino)benzoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2144−53−8 : Tridecafluorohexylethyl methacrylate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2144−53−8 : Tridecafluorohexylethyl methacrylate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 214535−77−0 : CP−457677 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 214535−77−0 : CP−457677 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 215297−27−1 : UK−343664 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 215297−27−1 : UK−343664 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2155−70−6 : Tributyltin methacrylate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2155−70−6 : Tributyltin methacrylate Agonist: 0 Antagonist: 0.14

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 21564−17−0 : 2−(Thiocyanomethylthio)benzothiazole Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 21564−17−0 : 2−(Thiocyanomethylthio)benzothiazole Agonist: 0 Antagonist: 0.027

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2164−17−2 : Fluometuron Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2164−17−2 : Fluometuron Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 21662−09−9 : (4Z)−4−Decenal Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 21662−09−9 : (4Z)−4−Decenal Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 21725−46−2 : Cyanazine Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 21725−46−2 : Cyanazine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2176−62−7 : Pentachloropyridine Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2176−62−7 : Pentachloropyridine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 219714−96−2 : Penoxsulam Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 219714−96−2 : Penoxsulam Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 219790−72−4 : SB281832 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 219790−72−4 : SB281832 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 22047−49−0 : 2−Ethylhexyl octadecanoate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 22047−49−0 : 2−Ethylhexyl octadecanoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 220860−50−4 : CP−457920 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 220860−50−4 : CP−457920 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 221246−12−4 : Fandosentan potassium salt Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 221246−12−4 : Fandosentan potassium salt Agonist: 0 Antagonist: 0.053

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2212−67−1 : Molinate Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2212−67−1 : Molinate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 221671−62−1 : SR146131 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 221671−62−1 : SR146131 Agonist: 0.0032 Antagonist: 0.029

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 22224−92−6 : Fenamiphos Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 22224−92−6 : Fenamiphos Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 22248−79−9 : Z−Tetrachlorvinphos Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 22248−79−9 : Z−Tetrachlorvinphos Agonist: 0 Antagonist: 0.026

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 22260−51−1 : Bromocriptine mesylate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 22260−51−1 : Bromocriptine mesylate Agonist: 0 Antagonist: 0.24

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2231−57−4 : Thiocarbazide Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2231−57−4 : Thiocarbazide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2243−62−1 : 1,5−Naphthalenediamine Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2243−62−1 : 1,5−Naphthalenediamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2244−21−5 : Potassium dichloroisocyanurate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2244−21−5 : Potassium dichloroisocyanurate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 22781−23−3 : Bendiocarb Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 22781−23−3 : Bendiocarb Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 22839−47−0 : Aspartame Chemical QC [ ? ? ? ? N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 22839−47−0 : Aspartame Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 22915−73−7 : Hexane−1,6−diyl dibenzoate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 22915−73−7 : Hexane−1,6−diyl dibenzoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 23031−36−9 : Prallethrin Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 23031−36−9 : Prallethrin Agonist: 0.0071 Antagonist: 0.12

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2303−17−5 : Tri−allate Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2303−17−5 : Tri−allate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 23089−26−1 : Levomenol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 23089−26−1 : Levomenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 230954−09−3 : CP−544439 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 230954−09−3 : CP−544439 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2310−17−0 : Phosalone Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2310−17−0 : Phosalone Agonist: 0 Antagonist: 0.034

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 23103−98−2 : Pirimicarb Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 23103−98−2 : Pirimicarb Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2312−35−8 : Propargite Chemical QC [ N.D. N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2312−35−8 : Propargite Agonist: 0 Antagonist: 0.14

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 23135−22−0 : Oxamyl Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 23135−22−0 : Oxamyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 23184−66−9 : Butachlor Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 23184−66−9 : Butachlor Agonist: 0.0028 Antagonist: 0.1

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2321−07−5 : Fluorescein Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2321−07−5 : Fluorescein Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 23386−52−9 : Dicyclohexyl sodium sulfosuccinate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 23386−52−9 : Dicyclohexyl sodium sulfosuccinate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 23422−53−9 : Formetanate hydrochloride Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 23422−53−9 : Formetanate hydrochloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2353−45−9 : FD&C Green No. 3 Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2353−45−9 : FD&C Green No. 3 Agonist: 0 Antagonist: 0.064

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 23564−05−8 : Thiophanate−methyl Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 23564−05−8 : Thiophanate−methyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 23564−06−9 : Thiophanate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 23564−06−9 : Thiophanate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 23593−75−1 : Clotrimazole Chemical QC [ ? N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 23593−75−1 : Clotrimazole Agonist: 0 Antagonist: 0.022

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 23779−32−0 : 1−[3−(Triethoxysilyl)propyl]urea Chemical QC [ ? ? ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 23779−32−0 : 1−[3−(Triethoxysilyl)propyl]urea Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2385−85−5 : Mirex Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2385−85−5 : Mirex Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2386−87−0 : UT−632 Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2386−87−0 : UT−632 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2390−60−5 : Basic Blue 7 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2390−60−5 : Basic Blue 7 Agonist: 0 Antagonist: 0.41

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2392−39−4 : Dexamethasone sodium phosphate Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2392−39−4 : Dexamethasone sodium phosphate Agonist: 0.22 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 23950−58−5 : Propyzamide Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 23950−58−5 : Propyzamide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2396−68−1 : 4−tert−Butylbenzenethiol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2396−68−1 : 4−tert−Butylbenzenethiol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2409−55−4 : 2−tert−Butyl−4−methylphenol Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2409−55−4 : 2−tert−Butyl−4−methylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 24157−81−1 : 2,6−Diisopropylnaphthalene Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 24157−81−1 : 2,6−Diisopropylnaphthalene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 24169−02−6 : Econazole nitrate Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 24169−02−6 : Econazole nitrate Agonist: 0.0018 Antagonist: 0.11

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2416−94−6 : 2,3,6−Trimethylphenol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2416−94−6 : 2,3,6−Trimethylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2425−06−1 : Captafol Chemical QC [ N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2425−06−1 : Captafol Agonist: 0 Antagonist: 0.086

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2425−77−6 : 2−Hexyl−1−decanol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2425−77−6 : 2−Hexyl−1−decanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2426−08−6 : Butyl glycidyl ether Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2426−08−6 : Butyl glycidyl ether Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 24307−26−4 : Mepiquat chloride Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 24307−26−4 : Mepiquat chloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2432−87−3 : Dioctyl succinate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2432−87−3 : Dioctyl succinate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2433−14−9 : 4−Cyclohexylcyclohexanol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2433−14−9 : 4−Cyclohexylcyclohexanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2440−22−4 : 2−(2H−Benzotriazol−2−yl)−4−methylphenol Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2440−22−4 : 2−(2H−Benzotriazol−2−yl)−4−methylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2445−77−4 : 2−Methylbutyl isovalerate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2445−77−4 : 2−Methylbutyl isovalerate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2451−62−9 : Triglycidyl isocyanurate Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2451−62−9 : Triglycidyl isocyanurate Agonist: 0 Antagonist: 0.021

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 24549−06−2 : 2−Ethyl−6−methylaniline Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 24549−06−2 : 2−Ethyl−6−methylaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2457−01−4 : Barium bis(2−ethylhexanoate) Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2457−01−4 : Barium bis(2−ethylhexanoate) Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 24602−86−6 : Tridemorph Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 24602−86−6 : Tridemorph Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2465−27−2 : Auramine hydrochloride Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2465−27−2 : Auramine hydrochloride Agonist: 0 Antagonist: 0.074

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2467−02−9 : Bisphenol F Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2467−02−9 : Bisphenol F Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 24800−44−0 : Tripropylene glycol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 24800−44−0 : Tripropylene glycol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 24851−98−7 : Methyl dihydrojasmonate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 24851−98−7 : Methyl dihydrojasmonate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2491−38−5 : 2−Bromo−4−hydroxyacetophenone Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2491−38−5 : 2−Bromo−4−hydroxyacetophenone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2492−26−4 : Sodium 2−mercaptobenzothiolate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2492−26−4 : Sodium 2−mercaptobenzothiolate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 249296−43−3 : CJ−013610 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 249296−43−3 : CJ−013610 Agonist: 0 Antagonist: 8.9e−05

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25057−89−0 : Bentazone Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25057−89−0 : Bentazone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25155−18−4 : Methylbenzethonium chloride Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25155−18−4 : Methylbenzethonium chloride Agonist: 0 Antagonist: 0.26

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25155−30−0 : Sodium dodecylbenzenesulfonate Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25155−30−0 : Sodium dodecylbenzenesulfonate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25168−05−2 : Chlorotoluene Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25168−05−2 : Chlorotoluene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25265−71−8 : Dipropylene glycol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25265−71−8 : Dipropylene glycol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2528−16−7 : Monobenzyl phthalate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2528−16−7 : Monobenzyl phthalate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25322−69−4 : Polypropylene glycol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25322−69−4 : Polypropylene glycol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 253450−09−8 : Besonprodil Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 253450−09−8 : Besonprodil Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25360−10−5 : tert−Nonanethiol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25360−10−5 : tert−Nonanethiol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25496−72−4 : Glyceryl monooleate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25496−72−4 : Glyceryl monooleate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25498−49−1 : Tripropylene glycol monomethyl ether Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25498−49−1 : Tripropylene glycol monomethyl ether Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2550−40−5 : Dicyclohexyl disulfide Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2550−40−5 : Dicyclohexyl disulfide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2554−06−5 : 1,3,5,7−Tetramethyl−1,3,5,7−tetravinylcyclotetrasiloxane Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2554−06−5 : 1,3,5,7−Tetramethyl−1,3,5,7−tetravinylcyclotetrasiloxane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25550−98−5 : Diisodecylphenyl phosphite Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25550−98−5 : Diisodecylphenyl phosphite Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25606−41−1 : Propamocarb hydrochloride Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25606−41−1 : Propamocarb hydrochloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25638−17−9 : Butylnaphthalenesulfonic acid sodium salt Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25638−17−9 : Butylnaphthalenesulfonic acid sodium salt Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25812−30−0 : Gemfibrozil Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25812−30−0 : Gemfibrozil Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2593−15−9 : Etridiazole Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2593−15−9 : Etridiazole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25956−17−6 : Allura Red C.I.16035 Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 25956−17−6 : Allura Red C.I.16035 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 26002−80−2 : Phenothrin Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 26002−80−2 : Phenothrin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 26027−38−3 : Polyoxyethylene(10)nonylphenyl ether Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 26027−38−3 : Polyoxyethylene(10)nonylphenyl ether Agonist: 0 Antagonist: 0.031

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 26040−51−7 : Bis(2−ethylhexyl) tetrabromophthalate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 26040−51−7 : Bis(2−ethylhexyl) tetrabromophthalate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2605−79−0 : N,N−Dimethyldecylamine oxide Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2605−79−0 : N,N−Dimethyldecylamine oxide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2610−11−9 : C.I. Direct Red 81 disodium salt Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2610−11−9 : C.I. Direct Red 81 disodium salt Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 26172−55−4 : 5−Chloro−2−methyl−3(2H)−isothiazolone Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 26172−55−4 : 5−Chloro−2−methyl−3(2H)−isothiazolone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 261947−38−0 : CP−532623 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 261947−38−0 : CP−532623 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 26225−79−6 : Ethofumesate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 26225−79−6 : Ethofumesate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 262376−75−0 : HMR1426 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 262376−75−0 : HMR1426 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 26264−06−2 : Calcium dodecylbenzene sulfonate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 26264−06−2 : Calcium dodecylbenzene sulfonate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2627−95−4 : 1,3−Divinyl−1,1,3,3−tetramethyl disiloxane Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2627−95−4 : 1,3−Divinyl−1,1,3,3−tetramethyl disiloxane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2634−33−5 : 1,2−Benzisothiazolin−3−one Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2634−33−5 : 1,2−Benzisothiazolin−3−one Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 263553−33−9 : GW473178E methyl benzene sulphonic acid Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 263553−33−9 : GW473178E methyl benzene sulphonic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 26402−26−6 : Glyceryl monooctanoate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 26402−26−6 : Glyceryl monooctanoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 26447−10−9 : Ammonium xylene sulfonate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 26447−10−9 : Ammonium xylene sulfonate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 264618−44−2 : SSR146977 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 264618−44−2 : SSR146977 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 26530−20−1 : Octhilinone Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 26530−20−1 : Octhilinone Agonist: 0 Antagonist: 0.069

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 26628−22−8 : Sodium azide Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 26628−22−8 : Sodium azide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 26644−46−2 : Triforine Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 26644−46−2 : Triforine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2675−77−6 : Chloroneb Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2675−77−6 : Chloroneb Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2687−25−4 : 2,3−Diaminotoluene Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2687−25−4 : 2,3−Diaminotoluene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2687−94−7 : N−Octyl−2−pyrrolidone Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2687−94−7 : N−Octyl−2−pyrrolidone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2687−96−9 : 1−Dodecyl−2−pyrrolidinone Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2687−96−9 : 1−Dodecyl−2−pyrrolidinone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 26896−20−8 : Neodecanoic acid Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 26896−20−8 : Neodecanoic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2694−54−4 : Triprop−2−en−1−yl benzene−1,2,4−tricarboxylate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2694−54−4 : Triprop−2−en−1−yl benzene−1,2,4−tricarboxylate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2696−84−6 : 4−Propylaniline Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2696−84−6 : 4−Propylaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2702−72−9 : 2,4−D sodium salt Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2702−72−9 : 2,4−D sodium salt Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 27090−63−7 : N,N,N',N'−Tetrabutyl−1,6−hexanediamine Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 27090−63−7 : N,N,N',N'−Tetrabutyl−1,6−hexanediamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 27138−31−4 : Di(propylene glycol) dibenzoate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 27138−31−4 : Di(propylene glycol) dibenzoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 27176−87−0 : Dodecylbenzenesulfonic acid Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 27176−87−0 : Dodecylbenzenesulfonic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 27178−16−1 : Diisodecyl hexanedioate Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 27178−16−1 : Diisodecyl hexanedioate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 271−89−6 : 2,3−Benzofuran Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 271−89−6 : 2,3−Benzofuran Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 27193−86−8 : Dodecylphenol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 27193−86−8 : Dodecylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 27253−33−4 : Calcium neodecanoate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 27253−33−4 : Calcium neodecanoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 27306−78−1 : Silwet L77 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 27306−78−1 : Silwet L77 Agonist: 0 Antagonist: 0.05

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 27314−13−2 : Norflurazon Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 27314−13−2 : Norflurazon Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 27323−41−7 : Dodecylbenzene sulfonate triethanolamine (1:1) Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 27323−41−7 : Dodecylbenzene sulfonate triethanolamine (1:1) Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 27344−41−8 : Disodium 4,4'−bis(2−sulfostyryl)biphenyl Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 27344−41−8 : Disodium 4,4'−bis(2−sulfostyryl)biphenyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2756−56−1 : Isobornyl propanoate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2756−56−1 : Isobornyl propanoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2761−24−2 : Triethoxypentylsilane Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2761−24−2 : Triethoxypentylsilane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2772−45−4 : 2,4−Bis(1−methyl−1−phenylethyl)phenol Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2772−45−4 : 2,4−Bis(1−methyl−1−phenylethyl)phenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2782−57−2 : Troclosene Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2782−57−2 : Troclosene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2783−94−0 : FD&C Yellow 6 Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2783−94−0 : FD&C Yellow 6 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2795−39−3 : PFOS−K Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2795−39−3 : PFOS−K Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 27955−94−8 : 4,4',4−Ethane−1,1,1−triyltriphenol Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 27955−94−8 : 4,4',4−Ethane−1,1,1−triyltriphenol Agonist: 0 Antagonist: 0.14

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2807−30−9 : 2−Propoxyethanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2807−30−9 : 2−Propoxyethanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 28159−98−0 : Cybutryne Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 28159−98−0 : Cybutryne Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 28249−77−6 : Thiobencarb Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 28249−77−6 : Thiobencarb Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 283594−90−1 : Spiromesifen Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 283594−90−1 : Spiromesifen Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2835−95−2 : 5−Amino−2−methylphenol Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2835−95−2 : 5−Amino−2−methylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 28434−00−6 : S−Bioallethrin Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 28434−00−6 : S−Bioallethrin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 28631−66−5 : C.I. Acid Blue 22 Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 28631−66−5 : C.I. Acid Blue 22 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2870−32−8 : C.I. Direct Yellow 12 Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2870−32−8 : C.I. Direct Yellow 12 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 28804−88−8 : Dimethylnaphthalene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 28804−88−8 : Dimethylnaphthalene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 288104−79−0 : Surinabant Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 288104−79−0 : Surinabant Agonist: 0 Antagonist: 0.035

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 288−32−4 : Imidazole Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 288−32−4 : Imidazole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 288−88−0 : 1H−1,2,4−Triazole Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 288−88−0 : 1H−1,2,4−Triazole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2893−78−9 : Sodium dichloroisocyanurate Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2893−78−9 : Sodium dichloroisocyanurate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 289716−94−5 : CP−607366 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 289716−94−5 : CP−607366 Agonist: 0 Antagonist: 0.028

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 290352−28−2 : CP−634384 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 290352−28−2 : CP−634384 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 29091−21−2 : Prodiamine Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 29091−21−2 : Prodiamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 29122−68−7 : Atenolol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 29122−68−7 : Atenolol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 291305−06−1 : UK−373911 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 291305−06−1 : UK−373911 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2917−73−9 : Dibutyl nonanedioate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2917−73−9 : Dibutyl nonanedioate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2919−66−6 : Melengestrol acetate Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2919−66−6 : Melengestrol acetate Agonist: 0.25 Antagonist: 0.18

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2921−88−2 : Chlorpyrifos Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2921−88−2 : Chlorpyrifos Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 29232−93−7 : Pirimiphos−methyl Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 29232−93−7 : Pirimiphos−methyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2934−05−6 : 2,4−Diisopropylphenol Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2934−05−6 : 2,4−Diisopropylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 29385−43−1 : Tolyltriazole Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 29385−43−1 : Tolyltriazole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 29387−86−8 : Propylene glycol monobutyl ether Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 29387−86−8 : Propylene glycol monobutyl ether Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 29420−49−3 : PFBS−K Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 29420−49−3 : PFBS−K Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2943−75−1 : Triethoxyoctylsilane Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2943−75−1 : Triethoxyoctylsilane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 29590−42−9 : Isooctyl acrylate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 29590−42−9 : Isooctyl acrylate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2971−36−0 : 2,2−Bis(4−hydroxyphenyl)−1,1,1−trichloroethane Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2971−36−0 : 2,2−Bis(4−hydroxyphenyl)−1,1,1−trichloroethane Agonist: 0 Antagonist: 0.29

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 298−00−0 : Methyl parathion Chemical QC [ N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 298−00−0 : Methyl parathion Agonist: 4.9e−05 Antagonist: 5.2e−05

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 298−02−2 : Phorate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 298−02−2 : Phorate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 298−04−4 : Disulfoton Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 298−04−4 : Disulfoton Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 298−07−7 : Bis(2−ethylhexyl) phosphate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 298−07−7 : Bis(2−ethylhexyl) phosphate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 298198−52−4 : SSR180711 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 298198−52−4 : SSR180711 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 29836−26−8 : Octyl beta−D−glucopyranoside Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 29836−26−8 : Octyl beta−D−glucopyranoside Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 298−46−4 : Carbamazepine Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 298−46−4 : Carbamazepine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2996−92−1 : Trimethoxyphenylsilane Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 2996−92−1 : Trimethoxyphenylsilane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 300−76−5 : Naled Chemical QC [ ? N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 300−76−5 : Naled Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3025−30−7 : Ethyl (2E,4Z)−deca−2,4−dienoate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3025−30−7 : Ethyl (2E,4Z)−deca−2,4−dienoate Agonist: 0 Antagonist: 0.028

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3026−63−9 : Sodium tridecyl sulfate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3026−63−9 : Sodium tridecyl sulfate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 302−79−4 : trans−Retinoic acid Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 302−79−4 : trans−Retinoic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3033−77−0 : N,N,N−Trimethyl(oxiran−2−yl)methanaminium chloride Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3033−77−0 : N,N,N−Trimethyl(oxiran−2−yl)methanaminium chloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 30399−84−9 : Isooctadecanoic acid Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 30399−84−9 : Isooctadecanoic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 30516−87−1 : 3'−Azido−3'−deoxythymidine Chemical QC [ N.D. P P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 30516−87−1 : 3'−Azido−3'−deoxythymidine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 30560−19−1 : Acephate Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 30560−19−1 : Acephate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3056−17−5 : Stavudine Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3056−17−5 : Stavudine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 307−24−4 : PFHxA Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 307−24−4 : PFHxA Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 309−00−2 : Aldrin Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 309−00−2 : Aldrin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 311−45−5 : Paraoxon Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 311−45−5 : Paraoxon Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 31218−83−4 : Propetamphos Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 31218−83−4 : Propetamphos Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 313994−79−5 : MK−578 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 313994−79−5 : MK−578 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 314−40−9 : Bromacil Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 314−40−9 : Bromacil Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3147−75−9 : Octrizole Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3147−75−9 : Octrizole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 31519−22−9 : 1,4−Dihydroxy−2−naphthoic acid Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 31519−22−9 : 1,4−Dihydroxy−2−naphthoic acid Agonist: 0 Antagonist: 0.069

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3164−85−0 : Potassium 2−ethylhexanoate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3164−85−0 : Potassium 2−ethylhexanoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3194−55−6 : 1,2,5,6,9,10−Hexabromocyclododecane Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3194−55−6 : 1,2,5,6,9,10−Hexabromocyclododecane Agonist: 0 Antagonist: 0.033

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 319−85−7 : beta−Hexachlorocyclohexane Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 319−85−7 : beta−Hexachlorocyclohexane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 32388−55−9 : 1−Cedr−8−en−9−ylethanone Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 32388−55−9 : 1−Cedr−8−en−9−ylethanone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3252−43−5 : Dibromoacetonitrile Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3252−43−5 : Dibromoacetonitrile Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3268−49−3 : 3−(Methylthio)propanal Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3268−49−3 : 3−(Methylthio)propanal Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 32809−16−8 : Procymidone Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 32809−16−8 : Procymidone Agonist: 0 Antagonist: 0.17

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 328−84−7 : 1,2−Dichloro−4−(trifluoromethyl)benzene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 328−84−7 : 1,2−Dichloro−4−(trifluoromethyl)benzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3296−90−0 : 2,2−Bis(bromomethyl)−1,3−propanediol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3296−90−0 : 2,2−Bis(bromomethyl)−1,3−propanediol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 330198−91−9 : Fully acetylated glycerol monoester on 12−Hydroxystearic acid (85%); Fully acetylated glycerol monostearate represents (10%) Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 330198−91−9 : Fully acetylated glycerol monoester on 12−Hydroxystearic acid (85%); Fully acetylated glycerol monostearate represents (10%) Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 330−54−1 : Diuron Chemical QC [ N.D. P P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 330−54−1 : Diuron Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 330−55−2 : Linuron Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 330−55−2 : Linuron Agonist: 0 Antagonist: 0.044

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 33089−61−1 : Amitraz Chemical QC [ ? N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 33089−61−1 : Amitraz Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 331623−06−4 : MK−547 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 331623−06−4 : MK−547 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3319−31−1 : Tris(2−ethylhexyl) trimellitate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3319−31−1 : Tris(2−ethylhexyl) trimellitate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 33228−44−3 : 4−Pentylaniline Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 33228−44−3 : 4−Pentylaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 33228−45−4 : 4−Hexylaniline Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 33228−45−4 : 4−Hexylaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 333−41−5 : Diazinon Chemical QC [ N.D. P P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 333−41−5 : Diazinon Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3337−71−1 : Asulam Chemical QC [ ? ? ? P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3337−71−1 : Asulam Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 334−48−5 : Decanoic acid Chemical QC [ N.D. N.D. N.D. P−MW ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 334−48−5 : Decanoic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 335−67−1 : PFOA Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 335−67−1 : PFOA Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 335−76−2 : PFDA Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 335−76−2 : PFDA Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 33629−47−9 : Butralin Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 33629−47−9 : Butralin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 33703−08−1 : Hexanedioic acid, diisononyl ester Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 33703−08−1 : Hexanedioic acid, diisononyl ester Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3380−34−5 : Triclosan Chemical QC [ ? N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3380−34−5 : Triclosan Agonist: 0.0088 Antagonist: 0.2

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 33820−53−0 : Isopropalin Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 33820−53−0 : Isopropalin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3383−96−8 : Temephos Chemical QC [ N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3383−96−8 : Temephos Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3391−86−4 : 1−Octen−3−ol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3391−86−4 : 1−Octen−3−ol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 33956−49−9 : Codlelure Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 33956−49−9 : Codlelure Agonist: 0 Antagonist: 0.023

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 34014−18−1 : Tebuthiuron Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 34014−18−1 : Tebuthiuron Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 34256−82−1 : Acetochlor Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 34256−82−1 : Acetochlor Agonist: 0 Antagonist: 0.11

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 34451−19−9 : Butyl (2S)−2−hydroxypropanoate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 34451−19−9 : Butyl (2S)−2−hydroxypropanoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 344930−95−6 : SSR69071 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 344930−95−6 : SSR69071 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3452−97−9 : 3,5,5−Trimethyl−1−hexanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3452−97−9 : 3,5,5−Trimethyl−1−hexanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 34590−94−8 : Propanol, 1(or 2)−(2−methoxymethylethoxy)− Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 34590−94−8 : Propanol, 1(or 2)−(2−methoxymethylethoxy)− Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 349495−42−7 : PharmaGSID_47263 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 349495−42−7 : PharmaGSID_47263 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 35256−85−0 : Butam Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 35256−85−0 : Butam Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 353280−07−6 : CP−612372 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 353280−07−6 : CP−612372 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 35367−38−5 : Diflubenzuron Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 35367−38−5 : Diflubenzuron Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 35400−43−2 : Sulprofos Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 35400−43−2 : Sulprofos Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3547−33−9 : 2−Hydroxyethyl octyl sulfide Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3547−33−9 : 2−Hydroxyethyl octyl sulfide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 35554−44−0 : Imazalil Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 35554−44−0 : Imazalil Agonist: 0.0083 Antagonist: 0.14

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 35575−96−3 : Azamethiphos Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 35575−96−3 : Azamethiphos Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 35691−65−7 : 1,2−Dibromo−2,4−dicyanobutane Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 35691−65−7 : 1,2−Dibromo−2,4−dicyanobutane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 361343−19−3 : Elzasonan Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 361343−19−3 : Elzasonan Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 361377−29−9 : Fluoxastrobin Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 361377−29−9 : Fluoxastrobin Agonist: 0 Antagonist: 0.033

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3622−84−2 : N−Butylbenzenesulfonamide Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3622−84−2 : N−Butylbenzenesulfonamide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3653−48−3 : MCPA−sodium Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3653−48−3 : MCPA−sodium Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 36631−30−8 : Triisodecyl trimellitate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 36631−30−8 : Triisodecyl trimellitate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 36653−82−4 : 1−Hexadecanol Chemical QC [ N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 36653−82−4 : 1−Hexadecanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 36673−16−2 : Isopropyl triethanolamine titanate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 36673−16−2 : Isopropyl triethanolamine titanate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 36734−19−7 : Iprodione Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 36734−19−7 : Iprodione Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3681−71−8 : (3Z)−3−Hexenyl acetate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3681−71−8 : (3Z)−3−Hexenyl acetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 368832−42−2 : CP−728663 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 368832−42−2 : CP−728663 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3691−35−8 : Chlorophacinone Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3691−35−8 : Chlorophacinone Agonist: 0 Antagonist: 0.1

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3734−33−6 : Denatonium benzoate Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3734−33−6 : Denatonium benzoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3734−67−6 : C.I. Acid Red 1 Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3734−67−6 : C.I. Acid Red 1 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3739−38−6 : 3−Phenoxybenzoic acid Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3739−38−6 : 3−Phenoxybenzoic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 375−85−9 : Perfluoroheptanoic acid Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 375−85−9 : Perfluoroheptanoic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 375−95−1 : PFNA Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 375−95−1 : PFNA Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 37764−25−3 : Dichlormid Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 37764−25−3 : Dichlormid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3811−04−9 : Potassium chlorate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3811−04−9 : Potassium chlorate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3811−73−2 : Sodium (2−pyridylthio)−N−oxide Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3811−73−2 : Sodium (2−pyridylthio)−N−oxide Agonist: 0 Antagonist: 0.00019

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3825−26−1 : PFOA, ammonium salt Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3825−26−1 : PFOA, ammonium salt Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3844−45−9 : FD&C Blue No. 1 Chemical QC [ P−MW P−MW ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3844−45−9 : FD&C Blue No. 1 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3855−32−1 : 2,6,10−Trimethyl−2,6,10−triazaundecane Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3855−32−1 : 2,6,10−Trimethyl−2,6,10−triazaundecane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3871−99−6 : PFHS−K Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3871−99−6 : PFHS−K Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3913−02−8 : 2−Butyloctan−1−ol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3913−02−8 : 2−Butyloctan−1−ol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 39236−46−9 : Imidazolidinyl urea Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 39236−46−9 : Imidazolidinyl urea Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3926−62−3 : Sodium chloroacetate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 3926−62−3 : Sodium chloroacetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 39300−45−3 : Dinocap Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 39300−45−3 : Dinocap Agonist: 0 Antagonist: 0.15

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 39515−41−8 : Fenpropathrin Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 39515−41−8 : Fenpropathrin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 39905−57−2 : 4−Hexyloxyaniline Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 39905−57−2 : 4−Hexyloxyaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 402910−27−4 : UK−416244 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 402910−27−4 : UK−416244 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 40487−42−1 : Pendimethalin Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 40487−42−1 : Pendimethalin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 40649−36−3 : 4−Propylcyclohexanone Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 40649−36−3 : 4−Propylcyclohexanone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4065−45−6 : Sulisobenzone Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4065−45−6 : Sulisobenzone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4098−71−9 : Isophorone diisocyanate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4098−71−9 : Isophorone diisocyanate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4107−98−6 : N,N−Diisopropylaniline Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4107−98−6 : N,N−Diisopropylaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 41198−08−7 : Profenofos Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 41198−08−7 : Profenofos Agonist: 0 Antagonist: 0.011

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4130−42−1 : 2,6−Di−tert−butyl−4−ethylphenol Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4130−42−1 : 2,6−Di−tert−butyl−4−ethylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 41372−08−1 : Methyldopa sesquihydrate Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 41372−08−1 : Methyldopa sesquihydrate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 41372−20−7 : Apomorphine hydrochloride hydrate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 41372−20−7 : Apomorphine hydrochloride hydrate Agonist: 0 Antagonist: 0.032

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 41481−66−7 : 4,4'−Sulfonylbis[2−(prop−2−en−1−yl)phenol] Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 41481−66−7 : 4,4'−Sulfonylbis[2−(prop−2−en−1−yl)phenol] Agonist: 0 Antagonist: 0.15

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4151−50−2 : Sulfluramid Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4151−50−2 : Sulfluramid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4180−23−8 : (E)−Anethole Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4180−23−8 : (E)−Anethole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 420−04−2 : Cyanamide Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 420−04−2 : Cyanamide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 42509−80−8 : Isazofos Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 42509−80−8 : Isazofos Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 427−51−0 : Cyproterone acetate Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 427−51−0 : Cyproterone acetate Agonist: 0.26 Antagonist: 0.069

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 42874−03−3 : Oxyfluorfen Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 42874−03−3 : Oxyfluorfen Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4291−63−8 : Cladribine Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4291−63−8 : Cladribine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 43121−43−3 : Triadimefon Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 43121−43−3 : Triadimefon Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 43222−48−6 : Difenzoquat metilsulfate Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 43222−48−6 : Difenzoquat metilsulfate Agonist: 0 Antagonist: 3e−04

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4342−36−3 : Tributyltin benzoate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4342−36−3 : Tributyltin benzoate Agonist: 0 Antagonist: 0.15

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4344−55−2 : 4−Butyloxyaniline Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4344−55−2 : 4−Butyloxyaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4376−18−5 : Monomethyl phthalate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4376−18−5 : Monomethyl phthalate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4376−20−9 : Mono(2−ethylhexyl) phthalate Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4376−20−9 : Mono(2−ethylhexyl) phthalate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 439687−69−1 : Nelivaptan Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 439687−69−1 : Nelivaptan Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4418−26−2 : Sodium dehydroacetate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4418−26−2 : Sodium dehydroacetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4437−85−8 : Butylene carbonate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4437−85−8 : Butylene carbonate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 444610−91−7 : PharmaGSID_47315 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 444610−91−7 : PharmaGSID_47315 Agonist: 0 Antagonist: 0.04

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4449−51−8 : Cyclopamine Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4449−51−8 : Cyclopamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 445295−04−5 : CP−671305 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 445295−04−5 : CP−671305 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4455−26−9 : N−Methyldioctylamine Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4455−26−9 : N−Methyldioctylamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 446−72−0 : Genistein Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 446−72−0 : Genistein Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4468−42−2 : 3−Phenylhexane Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4468−42−2 : 3−Phenylhexane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 446−86−6 : Azathioprine Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 446−86−6 : Azathioprine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 451−40−1 : 1,2−Diphenylethanone Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 451−40−1 : 1,2−Diphenylethanone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4548−53−2 : FD&C Red 4 Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4548−53−2 : FD&C Red 4 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4553−62−2 : 2−Methylpentanedinitrile Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4553−62−2 : 2−Methylpentanedinitrile Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4574−04−3 : Myristyltrimethylammonium chlorideN,N,N−Trimethyltetradecan−1−aminium chloride Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4574−04−3 : Myristyltrimethylammonium chlorideN,N,N−Trimethyltetradecan−1−aminium chloride Agonist: 0 Antagonist: 0.15

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 460−00−4 : 1−Bromo−4−fluorobenzene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 460−00−4 : 1−Bromo−4−fluorobenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 460081−99−6 : PharmaGSID_48510 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 460081−99−6 : PharmaGSID_48510 Agonist: 0.004 Antagonist: 0.13

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4602−84−0 : Farnesol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4602−84−0 : Farnesol Agonist: 0 Antagonist: 0.029

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 461023−63−2 : Aplaviroc hydrochloride Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 461023−63−2 : Aplaviroc hydrochloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 461−58−5 : Cyanoguanidine Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 461−58−5 : Cyanoguanidine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 463−40−1 : Linolenic acid Chemical QC [ ? N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 463−40−1 : Linolenic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4638−48−6 : 5−Chlorosalicylanilide Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4638−48−6 : 5−Chlorosalicylanilide Agonist: 0 Antagonist: 0.00041

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 464−49−3 : D−Camphor Chemical QC [ ? N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 464−49−3 : D−Camphor Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4707−47−5 : Methyl 2,4−dihydroxy−3,6−dimethylbenzoate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4707−47−5 : Methyl 2,4−dihydroxy−3,6−dimethylbenzoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 470−82−6 : 1,8−Cineol Chemical QC [ ? N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 470−82−6 : 1,8−Cineol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4712−55−4 : Diphenyl phosphite Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4712−55−4 : Diphenyl phosphite Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 473289−62−2 : Ilepatril Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 473289−62−2 : Ilepatril Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 474−86−2 : Equilin Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 474−86−2 : Equilin Agonist: 0.021 Antagonist: 0.28

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 478149−53−0 : PHA−00543613 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 478149−53−0 : PHA−00543613 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 478263−98−8 : AVE3295 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 478263−98−8 : AVE3295 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 480−40−0 : Chrysin Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 480−40−0 : Chrysin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 480−63−7 : 2,4,6−Trimethylbenzoic acid Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 480−63−7 : 2,4,6−Trimethylbenzoic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 484−17−3 : 9−Phenanthrol Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 484−17−3 : 9−Phenanthrol Agonist: 0 Antagonist: 0.19

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 486−56−6 : Cotinine Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 486−56−6 : Cotinine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 486−66−8 : Daidzein Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 486−66−8 : Daidzein Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 487−06−9 : 5,7−Dimethoxy−2H−chromen−2−one Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 487−06−9 : 5,7−Dimethoxy−2H−chromen−2−one Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 489−01−0 : 2,6−Di−tert−butyl−4−methoxyphenol Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 489−01−0 : 2,6−Di−tert−butyl−4−methoxyphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4904−61−4 : 1,5,9−Cyclododecatriene Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4904−61−4 : 1,5,9−Cyclododecatriene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 491−80−5 : Biochanin A Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 491−80−5 : Biochanin A Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 493−52−7 : Methyl red Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 493−52−7 : Methyl red Agonist: 0 Antagonist: 0.026

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4940−11−8 : 2−Ethyl−3−hydroxy−4H−pyran−4−one Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 4940−11−8 : 2−Ethyl−3−hydroxy−4H−pyran−4−one Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 49562−28−9 : Fenofibrate Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 49562−28−9 : Fenofibrate Agonist: 0 Antagonist: 0.044

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 496−46−8 : Glycoluril Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 496−46−8 : Glycoluril Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 496−72−0 : 3,4−Diaminotoluene Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 496−72−0 : 3,4−Diaminotoluene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 499−75−2 : Isopropyl−o−cresol Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 499−75−2 : Isopropyl−o−cresol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 499−83−2 : 2,6−Pyridinedicarboxylic acid Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 499−83−2 : 2,6−Pyridinedicarboxylic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 500−38−9 : Nordihydroguaiaretic acid Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 500−38−9 : Nordihydroguaiaretic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 501027−49−2 : PD−0333941 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 501027−49−2 : PD−0333941 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50−14−6 : Ergocalciferol Chemical QC [ N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50−14−6 : Ergocalciferol Agonist: 0 Antagonist: 0.019

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50−21−5 : Lactic acid Chemical QC [ N.D. N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50−21−5 : Lactic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50−22−6 : Corticosterone Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50−22−6 : Corticosterone Agonist: 0.63 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50−27−1 : Estriol Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50−27−1 : Estriol Agonist: 0 Antagonist: 0.025

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50−28−2 : 17beta−Estradiol Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50−28−2 : 17beta−Estradiol Agonist: 0.79 Antagonist: 0.06

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50−29−3 : p,p'−DDT Chemical QC [ N.D. N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50−29−3 : p,p'−DDT Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50−35−1 : Thalidomide Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50−35−1 : Thalidomide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50−41−9 : Clomiphene citrate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50−41−9 : Clomiphene citrate Agonist: 0 Antagonist: 0.17

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50471−44−8 : Vinclozolin Chemical QC [ N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50471−44−8 : Vinclozolin Agonist: 0 Antagonist: 0.2

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50−55−5 : Reserpine Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50−55−5 : Reserpine Agonist: 0 Antagonist: 0.081

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50594−66−6 : Acifluorfen Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50594−66−6 : Acifluorfen Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50−65−7 : Niclosamide Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50−65−7 : Niclosamide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50−70−4 : D−Glucitol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50−70−4 : D−Glucitol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50−78−2 : Aspirin Chemical QC [ ? N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50−78−2 : Aspirin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50−81−7 : L−Ascorbic acid

Chemical QC [ ? N.D. N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50−81−7 : L−Ascorbic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50892−23−4 : Pirinixic acid Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 50892−23−4 : Pirinixic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 510−15−6 : Chlorobenzilate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 510−15−6 : Chlorobenzilate Agonist: 0 Antagonist: 0.16

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51−03−6 : Piperonyl butoxide Chemical QC [ ? N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51−03−6 : Piperonyl butoxide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51−05−8 : Procaine hydrochloride Chemical QC [ N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51−05−8 : Procaine hydrochloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5116−94−9 : Monotridecyl phosphate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5116−94−9 : Monotridecyl phosphate Agonist: 0 Antagonist: 0.016

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51−21−8 : 5−Fluorouracil Chemical QC [ N.D. N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51−21−8 : 5−Fluorouracil Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51218−45−2 : Metolachlor Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51218−45−2 : Metolachlor Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51229−78−8 : Chloroallyl methenamine chloride Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51229−78−8 : Chloroallyl methenamine chloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51235−04−2 : Hexazinone Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51235−04−2 : Hexazinone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51−24−1 : Tiratricol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51−24−1 : Tiratricol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 512−42−5 : Sodium methyl sulfate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 512−42−5 : Sodium methyl sulfate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 512−56−1 : Trimethyl phosphate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 512−56−1 : Trimethyl phosphate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51−28−5 : 2,4−Dinitrophenol Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51−28−5 : 2,4−Dinitrophenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51−30−9 : Isoproterenol hydrochloride Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51−30−9 : Isoproterenol hydrochloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51338−27−3 : Diclofop−methyl Chemical QC [ P P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51338−27−3 : Diclofop−methyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5137−55−3 : Methyltrioctylammonium chloride Chemical QC [ ? ? ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5137−55−3 : Methyltrioctylammonium chloride Agonist: 0 Antagonist: 0.33

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5138−18−1 : Sulfosuccinic acid Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5138−18−1 : Sulfosuccinic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5146−66−7 : 2,6−Octadienenitrile, 3,7−dimethyl− Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5146−66−7 : 2,6−Octadienenitrile, 3,7−dimethyl− Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51−52−5 : 6−Propyl−2−thiouracil Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51−52−5 : 6−Propyl−2−thiouracil Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5153−25−3 : 2−Ethylhexylparaben Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5153−25−3 : 2−Ethylhexylparaben Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51580−86−0 : Sodium dichloro−s−triazinetrione dihydrate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51580−86−0 : Sodium dichloro−s−triazinetrione dihydrate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51630−58−1 : Fenvalerate Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51630−58−1 : Fenvalerate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51632−16−7 : 1−(Bromomethyl)−3−phenoxybenzene Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51632−16−7 : 1−(Bromomethyl)−3−phenoxybenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51707−55−2 : Thidiazuron Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51707−55−2 : Thidiazuron Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51−79−6 : Urethane Chemical QC [ N.D. N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 51−79−6 : Urethane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 52−01−7 : Spironolactone Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 52−01−7 : Spironolactone Agonist: 0.054 Antagonist: 0.29

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 520−18−3 : Kaempferol Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 520−18−3 : Kaempferol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 520−36−5 : Apigenin Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 520−36−5 : Apigenin Agonist: 5e−04 Antagonist: 0.1

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 520−45−6 : Dehydroacetic acid Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 520−45−6 : Dehydroacetic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 521−18−6 : 5alpha−Dihydrotestosterone Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 521−18−6 : 5alpha−Dihydrotestosterone Agonist: 1.1 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5216−25−1 : 4−Chlorobenzotrichloride Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5216−25−1 : 4−Chlorobenzotrichloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 52225−20−4 : dl−alpha−Tocopheryl acetate Chemical QC [ N.D. N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 52225−20−4 : dl−alpha−Tocopheryl acetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 52315−07−8 : Cypermethrin Chemical QC [ N.D. N.D. N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 52315−07−8 : Cypermethrin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5234−68−4 : Carboxin Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5234−68−4 : Carboxin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 52−51−7 : Bronopol Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 52−51−7 : Bronopol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 525−79−1 : Kinetin Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 525−79−1 : Kinetin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 525−82−6 : Flavone Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 525−82−6 : Flavone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 52645−53−1 : Permethrin Chemical QC [ N.D. N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 52645−53−1 : Permethrin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 526−75−0 : 2,3−Dimethylphenol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 526−75−0 : 2,3−Dimethylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 52−68−6 : Trichlorfon Chemical QC [ N.D. N.D. N.D. N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 52−68−6 : Trichlorfon Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 527−60−6 : 2,4,6−Trimethylphenol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 527−60−6 : 2,4,6−Trimethylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 527680−56−4 : PHA−00568487 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 527680−56−4 : PHA−00568487 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 52806−53−8 : Hydroxyflutamide Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 52806−53−8 : Hydroxyflutamide Agonist: 0 Antagonist: 0.55

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 528−29−0 : 1,2−Dinitrobenzene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 528−29−0 : 1,2−Dinitrobenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 52−86−8 : Haloperidol Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 52−86−8 : Haloperidol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 52918−63−5 : Deltamethrin Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 52918−63−5 : Deltamethrin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 53−03−2 : Prednisone Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 53−03−2 : Prednisone Agonist: 0.27 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 53112−28−0 : Pyrimethanil Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 53112−28−0 : Pyrimethanil Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5315−79−7 : 1−Hydroxypyrene Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5315−79−7 : 1−Hydroxypyrene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 53−16−7 : Estrone Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 53−16−7 : Estrone Agonist: 0.074 Antagonist: 0.26

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 53−19−0 : o,p'−DDD Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 53−19−0 : o,p'−DDD Agonist: 0 Antagonist: 0.043

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 532−02−5 : Sodium 2−naphthalenesulfonate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 532−02−5 : Sodium 2−naphthalenesulfonate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 53219−21−9 : 7−Octen−2−ol, 2−methyl−6−methylene−, dihydro deriv. Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 53219−21−9 : 7−Octen−2−ol, 2−methyl−6−methylene−, dihydro deriv. Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 532−27−4 : 2−Chloroacetophenone Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 532−27−4 : 2−Chloroacetophenone Agonist: 0.016 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 532−32−1 : Sodium benzoate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 532−32−1 : Sodium benzoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5329−14−6 : Sulfamic acid Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5329−14−6 : Sulfamic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 533−23−3 : 2,4−D−ethyl ester Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 533−23−3 : 2,4−D−ethyl ester Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5333−42−6 : 2−Octyl−1−dodecanol Chemical QC [ N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5333−42−6 : 2−Octyl−1−dodecanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 533−74−4 : Dazomet Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 533−74−4 : Dazomet Agonist: 0 Antagonist: 2.7e−05

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 534−13−4 : N,N'−Dimethylthiourea Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 534−13−4 : N,N'−Dimethylthiourea Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 53−43−0 : Dehydroepiandrosterone Chemical QC [ N.D. N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 53−43−0 : Dehydroepiandrosterone Agonist: 0.0062 Antagonist: 0.19

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 534−52−1 : 2−Methyl−4,6−dinitrophenol Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 534−52−1 : 2−Methyl−4,6−dinitrophenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5349−51−9 : 4−(2−Methylbutan−2−yl)cyclohexanol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5349−51−9 : 4−(2−Methylbutan−2−yl)cyclohexanol Agonist: 0 Antagonist: 2.6e−05

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 53−70−3 : Dibenz(a,h)anthracene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 53−70−3 : Dibenz(a,h)anthracene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 53−86−1 : Indomethacin Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 53−86−1 : Indomethacin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 53894−23−8 : Triisononyl trimellitate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 53894−23−8 : Triisononyl trimellitate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5392−40−5 : 3,7−Dimethyl−2,6−octadienal Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5392−40−5 : 3,7−Dimethyl−2,6−octadienal Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 53939−28−9 : (Z)−11−Hexadecenal Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 53939−28−9 : (Z)−11−Hexadecenal Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5394−36−5 : 5−Ethyl−5−methylhydantoin Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5394−36−5 : 5−Ethyl−5−methylhydantoin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 540−18−1 : Pentyl butyrate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 540−18−1 : Pentyl butyrate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5407−98−7 : Cyclobutyl phenyl ketone Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5407−98−7 : Cyclobutyl phenyl ketone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 540−88−5 : tert−Butyl acetate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 540−88−5 : tert−Butyl acetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 541−02−6 : Decamethylcyclopentasiloxane Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 541−02−6 : Decamethylcyclopentasiloxane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 54−11−5 : Nicotine Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 54−11−5 : Nicotine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 541−73−1 : 1,3−Dichlorobenzene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 541−73−1 : 1,3−Dichlorobenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 542−92−7 : 1,3−Cyclopentadiene Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 542−92−7 : 1,3−Cyclopentadiene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5437−45−6 : Benzyl bromoacetate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5437−45−6 : Benzyl bromoacetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 544−63−8 : Tetradecanoic acid Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 544−63−8 : Tetradecanoic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 544−76−3 : Hexadecane Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 544−76−3 : Hexadecane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 54593−83−8 : Chlorethoxyfos Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 54593−83−8 : Chlorethoxyfos Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 54−62−6 : 4−Aminofolic acid Chemical QC [ ? ? N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 54−62−6 : 4−Aminofolic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 54−85−3 : Isoniazid Chemical QC [ N.D. N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 54−85−3 : Isoniazid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 548−62−9 : Gentian Violet Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 548−62−9 : Gentian Violet Agonist: 0 Antagonist: 0.23

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 54965−24−1 : Tamoxifen citrate Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 54965−24−1 : Tamoxifen citrate Agonist: 0 Antagonist: 0.17

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 550−44−7 : N−Methylphthalimide Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 550−44−7 : N−Methylphthalimide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 55−18−5 : N−Nitrosodiethylamine Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 55−18−5 : N−Nitrosodiethylamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 55219−65−3 : Triadimenol Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 55219−65−3 : Triadimenol Agonist: 0 Antagonist: 6.8e−05

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 552−30−7 : Trimellitic anhydride Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 552−30−7 : Trimellitic anhydride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 55283−68−6 : Ethalfluralin Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 55283−68−6 : Ethalfluralin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 55285−14−8 : Carbosulfan Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 55285−14−8 : Carbosulfan Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 55290−64−7 : Dimethipin Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 55290−64−7 : Dimethipin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 553−26−4 : 4,4'−Bipyridine Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 553−26−4 : 4,4'−Bipyridine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 55335−06−3 : Triclopyr Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 55335−06−3 : Triclopyr Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5536−61−8 : Sodium methacrylate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5536−61−8 : Sodium methacrylate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 553−70−8 : Magnesium dibenzoate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 553−70−8 : Magnesium dibenzoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 55−38−9 : Fenthion Chemical QC [ N.D. N.D. N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 55−38−9 : Fenthion Agonist: 4.3e−05 Antagonist: 4.6e−05

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 55406−53−6 : 3−Iodo−2−propynyl−N−butylcarbamate Chemical QC [ P P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 55406−53−6 : 3−Iodo−2−propynyl−N−butylcarbamate Agonist: 0 Antagonist: 2.7e−05

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 55512−33−9 : Pyridate Chemical QC [ ? ? ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 55512−33−9 : Pyridate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 55589−62−3 : Acesulfame potassium Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 55589−62−3 : Acesulfame potassium Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 556−52−5 : Glycidol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 556−52−5 : Glycidol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 556−61−6 : Methyl isothiocyanate Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 556−61−6 : Methyl isothiocyanate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 556−67−2 : Octamethylcyclotetrasiloxane Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 556−67−2 : Octamethylcyclotetrasiloxane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 55814−41−0 : Mepronil Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 55814−41−0 : Mepronil Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 55934−93−5 : Tripropylene glycol butyl ether Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 55934−93−5 : Tripropylene glycol butyl ether Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 55−98−1 : Busulfan Chemical QC [ N.D. N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 55−98−1 : Busulfan Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5598−13−0 : Chlorpyrifos−methyl Chemical QC [ ? N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5598−13−0 : Chlorpyrifos−methyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5598−15−2 : Chlorpyrifos oxon Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5598−15−2 : Chlorpyrifos oxon Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 56−04−2 : 6−Methyl−2−thiouracil Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 56−04−2 : 6−Methyl−2−thiouracil Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 563−12−2 : Ethion Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 563−12−2 : Ethion Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 56375−79−2 : N,N−Dibutyl−N−methylbutan−1−aminium chloride Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 56375−79−2 : N,N−Dibutyl−N−methylbutan−1−aminium chloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 56−38−2 : Parathion Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 56−38−2 : Parathion Agonist: 0.00015 Antagonist: 0.00016

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 56−53−1 : Diethylstilbestrol Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 56−53−1 : Diethylstilbestrol Agonist: 0 Antagonist: 0.1

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 56−55−3 : Benz(a)anthracene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 56−55−3 : Benz(a)anthracene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 56−72−4 : Coumaphos Chemical QC [ N.D. P P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 56−72−4 : Coumaphos Agonist: 0 Antagonist: 0.03

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 56−81−5 : Glycerol Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 56−81−5 : Glycerol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 56−95−1 : Chlorhexidine diacetate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 56−95−1 : Chlorhexidine diacetate Agonist: 0 Antagonist: 0.17

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5700−49−2 : 1,2−Ethanediamine dihydriodide Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5700−49−2 : 1,2−Ethanediamine dihydriodide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−06−7 : Allyl isothiocyanate Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−06−7 : Allyl isothiocyanate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−09−0 : Hexadecyltrimethylammonium bromide Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−09−0 : Hexadecyltrimethylammonium bromide Agonist: 0 Antagonist: 0.18

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−10−3 : Hexadecanoic acid Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−10−3 : Hexadecanoic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−11−4 : Octadecanoic acid Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−11−4 : Octadecanoic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−13−6 : Urea Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−13−6 : Urea Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−14−7 : 1,1−Dimethylhydrazine Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−14−7 : 1,1−Dimethylhydrazine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 571−58−4 : 1,4−Dimethylnaphthalene Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 571−58−4 : 1,4−Dimethylnaphthalene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−30−7 : Phenobarbital sodium Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−30−7 : Phenobarbital sodium Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−41−0 : 5,5−Diphenylhydantoin Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−41−0 : 5,5−Diphenylhydantoin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−50−1 : Sucrose Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−50−1 : Sucrose Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−55−6 : 1,2−Propylene glycol Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−55−6 : 1,2−Propylene glycol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 576−26−1 : 2,6−Dimethylphenol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 576−26−1 : 2,6−Dimethylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−63−6 : 17alpha−Ethinylestradiol Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−63−6 : 17alpha−Ethinylestradiol Agonist: 0 Antagonist: 0.63

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 577−11−7 : Docusate sodium Chemical QC [ N.D. N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 577−11−7 : Docusate sodium Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−74−9 : Chlordane Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−74−9 : Chlordane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57754−85−5 : Clopyralid−olamine Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57754−85−5 : Clopyralid−olamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−83−0 : Progesterone Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−83−0 : Progesterone Agonist: 0.56 Antagonist: 0.077

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57837−19−1 : Metalaxyl Chemical QC [ N.D. P P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57837−19−1 : Metalaxyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−85−2 : Testosterone propionate Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−85−2 : Testosterone propionate Agonist: 1 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−91−0 : 17alpha−Estradiol Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−91−0 : 17alpha−Estradiol Agonist: 0.61 Antagonist: 0.053

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 579−66−8 : 2,6−Diethylaniline Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 579−66−8 : 2,6−Diethylaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57966−95−7 : Cymoxanil Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57966−95−7 : Cymoxanil Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−97−6 : 7,12−Dimethylbenz(a)anthracene Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 57−97−6 : 7,12−Dimethylbenz(a)anthracene Agonist: 0 Antagonist: 0.045

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 58−08−2 : Caffeine Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 58−08−2 : Caffeine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 58−14−0 : Pyrimethamine Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 58−14−0 : Pyrimethamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 58−18−4 : 17−Methyltestosterone Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 58−18−4 : 17−Methyltestosterone Agonist: 1.1 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 583−78−8 : 2,5−Dichlorophenol Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 583−78−8 : 2,5−Dichlorophenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 58394−64−2 : Benzyloctyl adipate Chemical QC [ ? ? ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 58394−64−2 : Benzyloctyl adipate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 584−13−4 : 4−Amino−1,2,4−triazole Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 584−13−4 : 4−Amino−1,2,4−triazole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 58430−94−7 : 3,5,5−Trimethylhexyl acetate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 58430−94−7 : 3,5,5−Trimethylhexyl acetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 584−79−2 : Allethrin Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 584−79−2 : Allethrin Agonist: 0 Antagonist: 0.033

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 584−84−9 : Toluene−2,4−diisocyanate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 584−84−9 : Toluene−2,4−diisocyanate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5850−86−2 : C.I. Acid Orange 8, monosodium salt Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5850−86−2 : C.I. Acid Orange 8, monosodium salt Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 585−34−2 : 3−tert−Butylphenol Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 585−34−2 : 3−tert−Butylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 58−55−9 : Theophylline Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 58−55−9 : Theophylline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 58−56−0 : Pyridoxine hydrochloride Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 58−56−0 : Pyridoxine hydrochloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 586−62−9 : Terpinolene Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 586−62−9 : Terpinolene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5870−93−9 : Heptyl butanoate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5870−93−9 : Heptyl butanoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 58−72−0 : Triphenylethylene Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 58−72−0 : Triphenylethylene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 587−65−5 : 2−Chloro−N−phenylacetamide Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 587−65−5 : 2−Chloro−N−phenylacetamide Agonist: 0 Antagonist: 0.092

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5877−42−9 : 4−Ethyloct−1−yn−3−ol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5877−42−9 : 4−Ethyloct−1−yn−3−ol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 587−85−9 : Diphenylmercury(II) Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 587−85−9 : Diphenylmercury(II) Agonist: 0 Antagonist: 0.042

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 58846−77−8 : Decyl beta−D−glucopyranoside Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 58846−77−8 : Decyl beta−D−glucopyranoside Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 58−85−5 : Biotin Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 58−85−5 : Biotin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 58−86−6 : D−Xylose Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 58−86−6 : D−Xylose Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 588941−45−1 : PharmaGSID_48506 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 588941−45−1 : PharmaGSID_48506 Agonist: 0 Antagonist: 0.097

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 58−89−9 : Lindane Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 58−89−9 : Lindane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 58−93−5 : Hydrochlorothiazide Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 58−93−5 : Hydrochlorothiazide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 589−68−4 : Tetradecanoic acid, 2,3−dihydroxypropyl ester Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 589−68−4 : Tetradecanoic acid, 2,3−dihydroxypropyl ester Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5902−51−2 : Terbacil Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5902−51−2 : Terbacil Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 59−05−2 : Methotrexate Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 59−05−2 : Methotrexate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5915−41−3 : Terbuthylazine Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 5915−41−3 : Terbuthylazine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 59227−89−3 : Laurocapram Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 59227−89−3 : Laurocapram Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 59−30−3 : Folic acid Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 59−30−3 : Folic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 59−40−5 : Sulfaquinoxaline Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 59−40−5 : Sulfaquinoxaline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 594−20−7 : 2,2−Dichloropropane Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 594−20−7 : 2,2−Dichloropropane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 59−50−7 : 4−Chloro−3−methylphenol Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 59−50−7 : 4−Chloro−3−methylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 59669−26−0 : Thiodicarb Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 59669−26−0 : Thiodicarb Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 59−67−6 : Nicotinic acid Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 59−67−6 : Nicotinic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 59756−60−4 : Fluridone Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 59756−60−4 : Fluridone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 598−55−0 : Methyl carbamate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 598−55−0 : Methyl carbamate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 59−87−0 : Nitrofurazone Chemical QC [ N.D. N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 59−87−0 : Nitrofurazone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 599−64−4 : 4−Cumylphenol Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 599−64−4 : 4−Cumylphenol Agonist: 0 Antagonist: 0.15

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 599−79−1 : Sulfasalazine Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 599−79−1 : Sulfasalazine Agonist: 9.9e−05 Antagonist: 1e−04

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 60−09−3 : 4−Aminoazobenzene Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 60−09−3 : 4−Aminoazobenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 60−12−8 : 2−Phenylethanol Chemical QC [ N.D. N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 60−12−8 : 2−Phenylethanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 60168−88−9 : Fenarimol Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 60168−88−9 : Fenarimol Agonist: 0 Antagonist: 0.035

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 602−01−7 : 2,3−Dinitrotoluene Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 602−01−7 : 2,3−Dinitrotoluene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 60207−90−1 : Propiconazole Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 60207−90−1 : Propiconazole Agonist: 0 Antagonist: 0.11

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 60−33−3 : Linoleic acid Chemical QC [ N.D. N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 60−33−3 : Linoleic acid Agonist: 0 Antagonist: 0.043

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 603−35−0 : Triphenylphosphine Chemical QC [ ? N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 603−35−0 : Triphenylphosphine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 60−35−5 : Acetamide Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 60−35−5 : Acetamide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 604−75−1 : Oxazepam Chemical QC [ P P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 604−75−1 : Oxazepam Agonist: 0.15 Antagonist: 0.067

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 60−51−5 : Dimethoate Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 60−51−5 : Dimethoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 605−45−8 : Diisopropyl phthalate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 605−45−8 : Diisopropyl phthalate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 60−54−8 : Tetracycline Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 60−54−8 : Tetracycline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6055−19−2 : Cyclophosphamide monohydrate Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6055−19−2 : Cyclophosphamide monohydrate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 60−56−0 : Methimazole Chemical QC [ N.D. N.D. N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 60−56−0 : Methimazole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 60−57−1 : Dieldrin Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 60−57−1 : Dieldrin Agonist: 0 Antagonist: 0.027

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 606−20−2 : 2,6−Dinitrotoluene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 606−20−2 : 2,6−Dinitrotoluene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6088−51−3 : 6−Hydroxy−2−naphthyl disulfide Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6088−51−3 : 6−Hydroxy−2−naphthyl disulfide Agonist: 0 Antagonist: 0.062

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 609−54−1 : 2,5−Dimethylbenzenesulfonic acid Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 609−54−1 : 2,5−Dimethylbenzenesulfonic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 611−20−1 : Benzonitrile, 2−hydroxy− Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 611−20−1 : Benzonitrile, 2−hydroxy− Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 611−70−1 : Isopropyl phenyl ketone Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 611−70−1 : Isopropyl phenyl ketone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 612−82−8 : 3,3'−Dimethylbenzidine dihydrochloride Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 612−82−8 : 3,3'−Dimethylbenzidine dihydrochloride Agonist: 0.046 Antagonist: 0.052

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 614−45−9 : tert−Butyl perbenzoate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 614−45−9 : tert−Butyl perbenzoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6149−03−7 : Sodium 4−octylbenzenesulfonate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6149−03−7 : Sodium 4−octylbenzenesulfonate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6152−33−6 : Sodium 2−phenylphenate tetrahydrate Chemical QC [ ? N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6152−33−6 : Sodium 2−phenylphenate tetrahydrate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6153−64−6 : Oxytetracycline dihydrate Chemical QC [ ? ? ? P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6153−64−6 : Oxytetracycline dihydrate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 616−45−5 : 2−Pyrrolidinone Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 616−45−5 : 2−Pyrrolidinone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 61−73−4 : Methylene blue Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 61−73−4 : Methylene blue Agonist: 0 Antagonist: 0.21

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 61791−12−6 : Cremophor(R) EL Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 61791−12−6 : Cremophor(R) EL Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 61−82−5 : Amitrole Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 61−82−5 : Amitrole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 618−45−1 : 3−Isopropylphenol Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 618−45−1 : 3−Isopropylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6190−65−4 : Deethylatrazine Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6190−65−4 : Deethylatrazine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 620−17−7 : 3−Ethylphenol Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 620−17−7 : 3−Ethylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 621−64−7 : N−Nitrosodipropylamine Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 621−64−7 : N−Nitrosodipropylamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 62−23−7 : 4−Nitrobenzoic acid Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 62−23−7 : 4−Nitrobenzoic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 622−97−9 : 4−Methylstyrene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 622−97−9 : 4−Methylstyrene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 62−38−4 : Phenylmercuric acetate Chemical QC [ ? N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 62−38−4 : Phenylmercuric acetate Agonist: 0 Antagonist: 0.12

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 625114−41−2 : Piragliatin Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 625114−41−2 : Piragliatin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 625−55−8 : Isopropyl formate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 625−55−8 : Isopropyl formate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 62−56−6 : Thiourea Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 62−56−6 : Thiourea Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6259−76−3 : Hexyl salicylate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6259−76−3 : Hexyl salicylate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 626−43−7 : 3,5−Dichloroaniline Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 626−43−7 : 3,5−Dichloroaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 627−18−9 : 3−Bromo−1−propanol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 627−18−9 : 3−Bromo−1−propanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 62−73−7 : Dichlorvos Chemical QC [ ? N.D. N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 62−73−7 : Dichlorvos Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 62−74−8 : Sodium fluoroacetate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 62−74−8 : Sodium fluoroacetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 62−75−9 : N−Nitrosodimethylamine Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 62−75−9 : N−Nitrosodimethylamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 627−93−0 : Dimethyl adipate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 627−93−0 : Dimethyl adipate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6285−05−8 : Ethyl 4−chlorophenyl ketone Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6285−05−8 : Ethyl 4−chlorophenyl ketone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 628−63−7 : Pentyl acetate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 628−63−7 : Pentyl acetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 62924−70−3 : Flumetralin Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 62924−70−3 : Flumetralin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 629−62−9 : Pentadecane Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 629−62−9 : Pentadecane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 629−76−5 : 1−Pentadecanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 629−76−5 : 1−Pentadecanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 630−56−8 : Hydroxyprogesterone caproate Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 630−56−8 : Hydroxyprogesterone caproate Agonist: 0.044 Antagonist: 0.23

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 63−05−8 : 4−Androstene−3,17−dione Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 63−05−8 : 4−Androstene−3,17−dione Agonist: 0.83 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6317−18−6 : Methylene bis(thiocyanate) Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6317−18−6 : Methylene bis(thiocyanate) Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 63−25−2 : Carbaryl Chemical QC [ ? N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 63−25−2 : Carbaryl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 633−96−5 : C.I. Acid Orange 7 Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 633−96−5 : C.I. Acid Orange 7 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 63−42−3 : Lactose Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 63−42−3 : Lactose Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6344−67−8 : 3−Hydroxyfluorene Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6344−67−8 : 3−Hydroxyfluorene Agonist: 0.0072 Antagonist: 0.084

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 63449−41−2 : C8−18−Alkydimethylbenzyl ammonium chlorides Chemical QC [ ? ? ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 63449−41−2 : C8−18−Alkydimethylbenzyl ammonium chlorides Agonist: 0 Antagonist: 0.14

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6359−82−6 : Acid Yellow 11 Chemical QC [ ? ? ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6359−82−6 : Acid Yellow 11 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6359−90−6 : C.I. Acid Yellow 34, monosodium salt Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6359−90−6 : C.I. Acid Yellow 34, monosodium salt Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6359−98−4 : C.I. Acid Yellow 17, disodium salt Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6359−98−4 : C.I. Acid Yellow 17, disodium salt Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 63612−50−0 : Nilutamide Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 63612−50−0 : Nilutamide Agonist: 0 Antagonist: 0.44

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 636−21−5 : 2−Methylaniline hydrochloride Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 636−21−5 : 2−Methylaniline hydrochloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 637−07−0 : Clofibrate Chemical QC [ N.D. N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 637−07−0 : Clofibrate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6381−77−7 : Sodium erythorbate (1:1) Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6381−77−7 : Sodium erythorbate (1:1) Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 64−10−8 : Urea, phenyl− Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 64−10−8 : Urea, phenyl− Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 64−19−7 : Acetic acid Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 64−19−7 : Acetic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6422−86−2 : Bis(2−ethylhexyl) terephthalate Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6422−86−2 : Bis(2−ethylhexyl) terephthalate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 64359−81−5 : 4,5−Dichloro−2−octyl−3(2H)−isothiazolone Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 64359−81−5 : 4,5−Dichloro−2−octyl−3(2H)−isothiazolone Agonist: 0.013 Antagonist: 0.034

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 643−79−8 : 1,2−Benzenedicarboxaldehyde Chemical QC [ ? N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 643−79−8 : 1,2−Benzenedicarboxaldehyde Agonist: 0 Antagonist: 0.022

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 644−97−3 : Phenyl phosphorus dichloride Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 644−97−3 : Phenyl phosphorus dichloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 645−56−7 : 4−Propylphenol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 645−56−7 : 4−Propylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 645−62−5 : 2−Ethyl−2−hexenal Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 645−62−5 : 2−Ethyl−2−hexenal Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6459−94−5 : C.I. Acid Red 114 Chemical QC [ N.D. N.D. P−MW ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6459−94−5 : C.I. Acid Red 114 Agonist: 0 Antagonist: 0.064

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 64−67−5 : Diethyl sulfate Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 64−67−5 : Diethyl sulfate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 64700−56−7 : Triclopyr−butotyl Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 64700−56−7 : Triclopyr−butotyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 647−42−7 : 3,3,4,4,5,5,6,6,7,7,8,8,8−Tridecafluorooctan−1−ol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 647−42−7 : 3,3,4,4,5,5,6,6,7,7,8,8,8−Tridecafluorooctan−1−ol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6485−40−1 : R−(−)−Carvone Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6485−40−1 : R−(−)−Carvone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 64−86−8 : Colchicine Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 64−86−8 : Colchicine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 648917−13−9 : AVE2865 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 648917−13−9 : AVE2865 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 650−51−1 : Sodium trichloroacetate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 650−51−1 : Sodium trichloroacetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 65−23−6 : Pyridoxine Chemical QC [ N.D. N.D. N.D. P−MW ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 65−23−6 : Pyridoxine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 65277−42−1 : Ketoconazole Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 65277−42−1 : Ketoconazole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 654055−01−3 : Morin hydrate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 654055−01−3 : Morin hydrate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 65−45−2 : Salicylamide Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 65−45−2 : Salicylamide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 657−84−1 : Sodium 4−methylbenzenesulfonate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 657−84−1 : Sodium 4−methylbenzenesulfonate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 65−85−0 : Benzoic acid Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 65−85−0 : Benzoic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6610−29−3 : N−Methylhydrazinecarbothioamide Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6610−29−3 : N−Methylhydrazinecarbothioamide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 66215−27−8 : Cyromazine Chemical QC [ N.D. N.D. N.D. N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 66215−27−8 : Cyromazine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 66230−04−4 : Esfenvalerate Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 66230−04−4 : Esfenvalerate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6624−73−3 : Pentane−1,5−diyl dibenzoate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6624−73−3 : Pentane−1,5−diyl dibenzoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6625−46−3 : C.I. Acid Violet 12, disodium salt Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6625−46−3 : C.I. Acid Violet 12, disodium salt Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 66−27−3 : Methyl methanesulfonate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 66−27−3 : Methyl methanesulfonate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 66332−96−5 : Flutolanil Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 66332−96−5 : Flutolanil Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 66357−35−5 : Ranitidine Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 66357−35−5 : Ranitidine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 66441−23−4 : Fenoxaprop−ethyl Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 66441−23−4 : Fenoxaprop−ethyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 66456−53−9 : Adipic acid, polypropyleneglycol, laurate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 66456−53−9 : Adipic acid, polypropyleneglycol, laurate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 66575−29−9 : Forskolin Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 66575−29−9 : Forskolin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 66−71−7 : 1,10−Phenanthroline Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 66−71−7 : 1,10−Phenanthroline Agonist: 0 Antagonist: 0.00021

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 66−81−9 : Cycloheximide Chemical QC [ N.D. N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 66−81−9 : Cycloheximide Agonist: 0 Antagonist: 0.21

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6683−19−8 : Irganox 1010 Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6683−19−8 : Irganox 1010 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 668981−02−0 : CP−863187 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 668981−02−0 : CP−863187 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6706−59−8 : L−Glucitol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6706−59−8 : L−Glucitol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 67−20−9 : Nitrofurantoin Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 67−20−9 : Nitrofurantoin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6728−26−3 : (2E)−2−Hexenal Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6728−26−3 : (2E)−2−Hexenal Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 67−30−1 : Tetrac Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 67−30−1 : Tetrac Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6734−80−1 : Metam−sodium hydrate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6734−80−1 : Metam−sodium hydrate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 67485−29−4 : Hydramethylnon Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 67485−29−4 : Hydramethylnon Agonist: 0.037 Antagonist: 0.023

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 67564−91−4 : (2R,6S)−Fenpropimorph Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 67564−91−4 : (2R,6S)−Fenpropimorph Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 676116−04−4 : PD 0343701 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 676116−04−4 : PD 0343701 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 67−68−5 : Dimethyl sulfoxide Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 67−68−5 : Dimethyl sulfoxide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 67747−09−5 : Prochloraz Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 67747−09−5 : Prochloraz Agonist: 0.0053 Antagonist: 0.15

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 67786−14−5 : Acid Red 337 Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 67786−14−5 : Acid Red 337 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 678−39−7 : 1,1,2,2−Tetrahydroperfluoro−1−decanol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 678−39−7 : 1,1,2,2−Tetrahydroperfluoro−1−decanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6789−88−4 : Hexyl benzoate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6789−88−4 : Hexyl benzoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68−11−1 : Thioglycolic acid Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68−11−1 : Thioglycolic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68−12−2 : N,N−Dimethylformamide Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68−12−2 : N,N−Dimethylformamide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68157−60−8 : Forchlorfenuron Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68157−60−8 : Forchlorfenuron Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68169−03−9 : 2−(Dihydrocyclopentadienyloxy)ethyl methacrylate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68169−03−9 : 2−(Dihydrocyclopentadienyloxy)ethyl methacrylate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 682−01−9 : Tetrapropyl orthosilicate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 682−01−9 : Tetrapropyl orthosilicate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68−22−4 : Norethindrone Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68−22−4 : Norethindrone Agonist: 1 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68−26−8 : Retinol Chemical QC [ ? N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68−26−8 : Retinol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 683−18−1 : Dibutyltin dichloride Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 683−18−1 : Dibutyltin dichloride Agonist: 0 Antagonist: 0.11

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68359−37−5 : Cyfluthrin Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68359−37−5 : Cyfluthrin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68392−35−8 : 4−Hydroxytamoxifen Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68392−35−8 : 4−Hydroxytamoxifen Agonist: 0 Antagonist: 0.18

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6846−50−0 : 2,2,4−Trimethyl−1,3−pentanediol diisobutyrate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6846−50−0 : 2,2,4−Trimethyl−1,3−pentanediol diisobutyrate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 684−93−5 : N−Nitroso−N−methylurea Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 684−93−5 : N−Nitroso−N−methylurea Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68515−48−0 : DINP branched Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68515−48−0 : DINP branched Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68515−49−1 : 1,2−Benzenedicarboxylic acid, di−C9−11−branched alkyl esters, C10−rich Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68515−49−1 : 1,2−Benzenedicarboxylic acid, di−C9−11−branched alkyl esters, C10−rich Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68515−75−3 : Hexanedioic acid, di−C7−9−branched and linear alkyl esters Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68515−75−3 : Hexanedioic acid, di−C7−9−branched and linear alkyl esters Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68555−86−2 : Acid Orange 156 Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68555−86−2 : Acid Orange 156 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68609−97−2 : C12−14−Alkyl glycidyl ether Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68609−97−2 : C12−14−Alkyl glycidyl ether Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 686756−87−6 : PharmaGSID_48519 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 686756−87−6 : PharmaGSID_48519 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68694−11−1 : Triflumizole Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68694−11−1 : Triflumizole Agonist: 0.0012 Antagonist: 0.12

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68917−18−0 : Cornmint oil Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68917−18−0 : Cornmint oil Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6893−02−3 : 3,5,3'−Triiodothyronine Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6893−02−3 : 3,5,3'−Triiodothyronine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68959−20−6 : Disiquonium chloride Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68959−20−6 : Disiquonium chloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68−96−2 : 17alpha−Hydroxyprogesterone Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 68−96−2 : 17alpha−Hydroxyprogesterone Agonist: 0.69 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 69−09−0 : Chlorpromazine hydrochloride Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 69−09−0 : Chlorpromazine hydrochloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6915−15−7 : Malic acid Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6915−15−7 : Malic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6923−22−4 : Monocrotophos Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 6923−22−4 : Monocrotophos Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 692−86−4 : Ethyl undec−10−enoate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 692−86−4 : Ethyl undec−10−enoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 69327−76−0 : Buprofezin Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 69327−76−0 : Buprofezin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 69377−81−7 : Fluroxypyr Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 69377−81−7 : Fluroxypyr Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 695−06−7 : gamma−Caprolactone Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 695−06−7 : gamma−Caprolactone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 69655−05−6 : 2',3'−Dideoxyinosine Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 69655−05−6 : 2',3'−Dideoxyinosine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 69−65−8 : D−Mannitol Chemical QC [ N.D. N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 69−65−8 : D−Mannitol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 69−72−7 : Salicylic acid Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 69−72−7 : Salicylic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 69−74−9 : Cytarabine hydrochloride Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 69−74−9 : Cytarabine hydrochloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 69806−40−2 : Haloxyfop−methyl Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 69806−40−2 : Haloxyfop−methyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 69806−50−4 : Fluazifop−butyl Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 69806−50−4 : Fluazifop−butyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7011−83−8 : 2(3H)−Furanone, 5−hexyldihydro−5−methyl− Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7011−83−8 : 2(3H)−Furanone, 5−hexyldihydro−5−methyl− Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 70−55−3 : 4−Toluenesulfonamide Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 70−55−3 : 4−Toluenesulfonamide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 705−60−2 : (2−Nitro−1−propenyl)benzene Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 705−60−2 : (2−Nitro−1−propenyl)benzene Agonist: 0 Antagonist: 0.05

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 70568−60−4 : 4−Butylcyclohexanol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 70568−60−4 : 4−Butylcyclohexanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 706−14−9 : gamma−Decanolactone Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 706−14−9 : gamma−Decanolactone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7080−50−4 : Chloramine−T trihydrate Chemical QC [ ? N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7080−50−4 : Chloramine−T trihydrate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 709−98−8 : Propanil Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 709−98−8 : Propanil Agonist: 0 Antagonist: 0.12

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 71−23−8 : 1−Propanol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 71−23−8 : 1−Propanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 712−50−5 : Cyclohexylphenylketone Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 712−50−5 : Cyclohexylphenylketone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 71283−80−2 : Fenoxaprop−P−ethyl Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 71283−80−2 : Fenoxaprop−P−ethyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 71526−07−3 : MON−4660 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 71526−07−3 : MON−4660 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7173−51−5 : Didecyldimethylammonium chloride Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7173−51−5 : Didecyldimethylammonium chloride Agonist: 0.011 Antagonist: 0.21

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 71751−41−2 : Abamectin Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 71751−41−2 : Abamectin Agonist: 0 Antagonist: 0.16

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 717−74−8 : 1,3,5−Triisopropylbenzene Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 717−74−8 : 1,3,5−Triisopropylbenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7212−44−4 : Nerolidol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7212−44−4 : Nerolidol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 72178−02−0 : Fomesafen Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 72178−02−0 : Fomesafen Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 72−20−8 : Endrin Chemical QC [ ? N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 72−20−8 : Endrin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 72−33−3 : Mestranol Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 72−33−3 : Mestranol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 72−43−5 : Methoxychlor Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 72−43−5 : Methoxychlor Agonist: 0 Antagonist: 0.033

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 72490−01−8 : Fenoxycarb Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 72490−01−8 : Fenoxycarb Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 725228−45−5 : AVE5638 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 725228−45−5 : AVE5638 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 72−54−8 : p,p'−DDD Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 72−54−8 : p,p'−DDD Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 72−55−9 : p,p'−DDE Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 72−55−9 : p,p'−DDE Agonist: 0.042 Antagonist: 0.064

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7287−19−6 : Prometryn Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7287−19−6 : Prometryn Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 732−11−6 : Phosmet Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 732−11−6 : Phosmet Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 73−22−3 : l−Tryptophan Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 73−22−3 : l−Tryptophan Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 732−26−3 : 2,4,6−Tris(tert−butyl)phenol Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 732−26−3 : 2,4,6−Tris(tert−butyl)phenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 73−31−4 : Melatonin Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 73−31−4 : Melatonin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7378−99−6 : N,N−Dimethyloctylamine Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7378−99−6 : N,N−Dimethyloctylamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7398−69−8 : Dimethyldiallylammonium chloride Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7398−69−8 : Dimethyldiallylammonium chloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 74051−80−2 : Sethoxydim Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 74051−80−2 : Sethoxydim Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 74115−24−5 : Clofentezine Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 74115−24−5 : Clofentezine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 741−58−2 : Bensulide Chemical QC [ P P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 741−58−2 : Bensulide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 742693−38−5 : SSR504734 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 742693−38−5 : SSR504734 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 744−45−6 : Diphenyl isophthalate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 744−45−6 : Diphenyl isophthalate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7487−94−7 : Mercuric chloride Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7487−94−7 : Mercuric chloride Agonist: 0 Antagonist: 3.6e−05

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 75−12−7 : Formamide Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 75−12−7 : Formamide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 75330−75−5 : Lovastatin Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 75330−75−5 : Lovastatin Agonist: 0 Antagonist: 0.054

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 753−73−1 : Dimethyltin dichloride Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 753−73−1 : Dimethyltin dichloride Agonist: 0 Antagonist: 0.036

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7540−51−4 : (S)−(−)−beta−Citronellol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7540−51−4 : (S)−(−)−beta−Citronellol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 754−91−6 : PFOSA Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 754−91−6 : PFOSA Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 75−50−3 : Trimethylamine Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 75−50−3 : Trimethylamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 75−60−5 : Dimethylarsinic acid Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 75−60−5 : Dimethylarsinic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 75−64−9 : tert−Butylamine Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 75−64−9 : tert−Butylamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 756−79−6 : Dimethyl methylphosphonate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 756−79−6 : Dimethyl methylphosphonate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 75−86−5 : 2−Hydroxy−2−methylpropanenitrile Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 75−86−5 : 2−Hydroxy−2−methylpropanenitrile Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 75−99−0 : Dalapon Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 75−99−0 : Dalapon Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 759−94−4 : EPTC Chemical QC [ P P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 759−94−4 : EPTC Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 760−23−6 : 3,4−Dichloro−1−butene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 760−23−6 : 3,4−Dichloro−1−butene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 76−03−9 : Trichloroacetic acid Chemical QC [ ? N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 76−03−9 : Trichloroacetic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 762−04−9 : Diethyl phosphite Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 762−04−9 : Diethyl phosphite Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7631−86−9 : Silica Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7631−86−9 : Silica Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7632−00−0 : Sodium nitrite Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7632−00−0 : Sodium nitrite Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 76−44−8 : Heptachlor Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 76−44−8 : Heptachlor Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 76−49−3 : Bornyl acetate Chemical QC [ ? N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 76−49−3 : Bornyl acetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 76578−14−8 : Quizalofop−ethyl Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 76578−14−8 : Quizalofop−ethyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7659−86−1 : 2−Ethylhexyl sulfanylacetate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7659−86−1 : 2−Ethylhexyl sulfanylacetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7664−38−2 : Phosphoric acid Chemical QC [ N.D. N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7664−38−2 : Phosphoric acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 76738−62−0 : Paclobutrazol Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 76738−62−0 : Paclobutrazol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7681−76−7 : Ronidazole Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7681−76−7 : Ronidazole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7681−82−5 : Sodium iodide Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7681−82−5 : Sodium iodide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 76−87−9 : Triphenyltin hydroxide Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 76−87−9 : Triphenyltin hydroxide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7696−12−0 : Tetramethrin Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7696−12−0 : Tetramethrin Agonist: 0 Antagonist: 0.038

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 769−92−6 : 4−tert−Butylaniline Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 769−92−6 : 4−tert−Butylaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 770−35−4 : 1−Phenoxy−2−propanol Chemical QC [ ? N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 770−35−4 : 1−Phenoxy−2−propanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−06−5 : Gibberellic acid Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−06−5 : Gibberellic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−09−8 : Phenolphthalein Chemical QC [ N.D. N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−09−8 : Phenolphthalein Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−40−7 : Bisphenol B Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−40−7 : Bisphenol B Agonist: 0 Antagonist: 0.13

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7747−35−5 : 5−Ethyl−1−aza−3,7−dioxabicyclo[3.3.0]octane Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7747−35−5 : 5−Ethyl−1−aza−3,7−dioxabicyclo[3.3.0]octane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−47−4 : Hexachlorocyclopentadiene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−47−4 : Hexachlorocyclopentadiene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−48−5 : 1,3−Dibromo−5,5−dimethylhydantoin Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−48−5 : 1,3−Dibromo−5,5−dimethylhydantoin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77501−63−4 : Lactofen Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77501−63−4 : Lactofen Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7757−79−1 : Potassium nitrate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7757−79−1 : Potassium nitrate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7758−19−2 : Sodium chlorite Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7758−19−2 : Sodium chlorite Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−71−4 : 5,5−Dimethylhydantoin Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−71−4 : 5,5−Dimethylhydantoin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7773−06−0 : Ammonium sulfamate Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7773−06−0 : Ammonium sulfamate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−73−6 : Dicyclopentadiene Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−73−6 : Dicyclopentadiene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7775−27−1 : Sodium persulfate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7775−27−1 : Sodium persulfate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−78−1 : Dimethyl sulfate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−78−1 : Dimethyl sulfate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7779−27−3 : 1,3,5−Triethylhexahydro−s−triazine Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7779−27−3 : 1,3,5−Triethylhexahydro−s−triazine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−83−8 : Ethyl methylphenylglycidate Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−83−8 : Ethyl methylphenylglycidate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7785−26−4 : (−)−alpha−Pinene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7785−26−4 : (−)−alpha−Pinene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−86−1 : Tromethamine Chemical QC [ N.D. N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−86−1 : Tromethamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7786−34−7 : Mevinphos Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 7786−34−7 : Mevinphos Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−89−4 : Acetyltriethyl citrate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−89−4 : Acetyltriethyl citrate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−90−7 : Acetyl tributyl citrate Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−90−7 : Acetyl tributyl citrate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−92−9 : Citric acid Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−92−9 : Citric acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−93−0 : Triethyl citrate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 77−93−0 : Triethyl citrate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78−07−9 : Ethyltriethoxysilane Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78−07−9 : Ethyltriethoxysilane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78−11−5 : Pentaerythritol tetranitrate Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78−11−5 : Pentaerythritol tetranitrate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78−40−0 : Triethyl phosphate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78−40−0 : Triethyl phosphate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78−42−2 : Tris(2−ethylhexyl) phosphate Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78−42−2 : Tris(2−ethylhexyl) phosphate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78473−71−9 : Enterolactone Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78473−71−9 : Enterolactone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78−48−8 : Tribufos Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78−48−8 : Tribufos Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78491−02−8 : Diazolidinyl urea Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78491−02−8 : Diazolidinyl urea Agonist: 4.6e−05 Antagonist: 4.9e−05

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78−51−3 : Tris(2−butoxyethyl) phosphate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78−51−3 : Tris(2−butoxyethyl) phosphate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78587−05−0 : Hexythiazox Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78587−05−0 : Hexythiazox Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78−59−1 : Isophorone Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78−59−1 : Isophorone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78−63−7 : 2,5−Dimethyl−2,5−di−(tert−butylperoxy)hexane Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78−63−7 : 2,5−Dimethyl−2,5−di−(tert−butylperoxy)hexane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78−69−3 : 3,7−Dimethyl−3−octanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78−69−3 : 3,7−Dimethyl−3−octanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78−70−6 : Linalool Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78−70−6 : Linalool Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78−82−0 : 2−Methylpropanenitrile Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78−82−0 : 2−Methylpropanenitrile Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 789−02−6 : o,p'−DDT Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 789−02−6 : o,p'−DDT Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78−96−6 : 1−Amino−2−propanol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 78−96−6 : 1−Amino−2−propanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79−06−1 : Acrylamide Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79−06−1 : Acrylamide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79098−20−7 : 4−Chloropentylbenzene Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79098−20−7 : 4−Chloropentylbenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79−14−1 : Glycolic acid Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79−14−1 : Glycolic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79−16−3 : N−Methylacetamide Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79−16−3 : N−Methylacetamide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79241−46−6 : Fluazifop−P−butyl Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79241−46−6 : Fluazifop−P−butyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79−24−3 : Nitroethane Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79−24−3 : Nitroethane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79277−27−3 : Thifensulfuron−methyl Chemical QC [ ? N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79277−27−3 : Thifensulfuron−methyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79−39−0 : Methacrylamide Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79−39−0 : Methacrylamide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79−43−6 : Dichloroacetic acid Chemical QC [ N.D. N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79−43−6 : Dichloroacetic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79−44−7 : Dimethylcarbamoyl chloride Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79−44−7 : Dimethylcarbamoyl chloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79538−32−2 : Tefluthrin Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79538−32−2 : Tefluthrin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79−57−2 : Oxytetracycline Chemical QC [ ? ? ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79−57−2 : Oxytetracycline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79622−59−6 : Fluazinam Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79622−59−6 : Fluazinam Agonist: 0 Antagonist: 0.12

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 797−63−7 : Norgestrel Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 797−63−7 : Norgestrel Agonist: 0.97 Antagonist: 0.0022

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79902−63−9 : Simvastatin Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79902−63−9 : Simvastatin Agonist: 0 Antagonist: 0.023

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79−92−5 : 2,2−Dimethyl−3−methylenebicyclo[2.2.1]heptane Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79−92−5 : 2,2−Dimethyl−3−methylenebicyclo[2.2.1]heptane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79−94−7 : 3,3',5,5'−Tetrabromobisphenol A Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79−94−7 : 3,3',5,5'−Tetrabromobisphenol A Agonist: 0 Antagonist: 0.016

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79−95−8 : 2,2',6,6'−Tetrachlorobisphenol A Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79−95−8 : 2,2',6,6'−Tetrachlorobisphenol A Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79983−71−4 : Hexaconazole Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 79983−71−4 : Hexaconazole Agonist: 0 Antagonist: 0.13

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 8000−34−8 : Clove leaf oil Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 8000−34−8 : Clove leaf oil Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 8000−41−7 : Terpineol Chemical QC [ ? N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 8000−41−7 : Terpineol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 8001−54−5 : Benzalkonium chloride Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 8001−54−5 : Benzalkonium chloride Agonist: 0 Antagonist: 0.13

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 8004−92−0 : C.I. Acid Yellow 3 disodium salt Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 8004−92−0 : C.I. Acid Yellow 3 disodium salt Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 80−05−7 : Bisphenol A Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 80−05−7 : Bisphenol A Agonist: 0 Antagonist: 0.14

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 8006−90−4 : Peppermint oil Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 8006−90−4 : Peppermint oil Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 8007−70−3 : Anise oil Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 8007−70−3 : Anise oil Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 80−07−9 : 4,4'−Dichlorodiphenyl sulfone Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 80−07−9 : 4,4'−Dichlorodiphenyl sulfone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 80−08−0 : Dapsone Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 80−08−0 : Dapsone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 80−09−1 : 4,4'−Sulfonyldiphenol Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 80−09−1 : 4,4'−Sulfonyldiphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 80−15−9 : Cumene hydroperoxide Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 80−15−9 : Cumene hydroperoxide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 8018−01−7 : Mancozeb Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 8018−01−7 : Mancozeb Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 80−26−2 : alpha−Terpinyl acetate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 80−26−2 : alpha−Terpinyl acetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 80−27−3 : Terpinyl propionate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 80−27−3 : Terpinyl propionate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 80−43−3 : Dicumyl peroxide Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 80−43−3 : Dicumyl peroxide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 80−46−6 : 4−(2−Methylbutan−2−yl)phenol Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 80−46−6 : 4−(2−Methylbutan−2−yl)phenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 80−54−6 : 3−(4−tert−Butylphenyl)−2−methylpropanal Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 80−54−6 : 3−(4−tert−Butylphenyl)−2−methylpropanal Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 80−56−8 : alpha−Pinene Chemical QC [ ? N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 80−56−8 : alpha−Pinene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 80844−07−1 : Etofenprox Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 80844−07−1 : Etofenprox Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 81−07−2 : Saccharin Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 81−07−2 : Saccharin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 81131−70−6 : Pravastatin sodium Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 81131−70−6 : Pravastatin sodium Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 81334−34−1 : Imazapyr Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 81334−34−1 : Imazapyr Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 81335−37−7 : Imazaquin Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 81335−37−7 : Imazaquin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 81335−77−5 : Imazethapyr Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 81335−77−5 : Imazethapyr Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 81405−85−8 : Imazmethabenz Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 81405−85−8 : Imazmethabenz Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 81406−37−3 : Fluroxypyr−meptyl Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 81406−37−3 : Fluroxypyr−meptyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 81741−28−8 : Tributyltetradecylphosphonium chloride Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 81741−28−8 : Tributyltetradecylphosphonium chloride Agonist: 0 Antagonist: 0.15

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 81777−89−1 : Clomazone Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 81777−89−1 : Clomazone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 81−81−2 : Warfarin Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 81−81−2 : Warfarin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 818−61−1 : 2−Hydroxyethyl acrylate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 818−61−1 : 2−Hydroxyethyl acrylate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 81−88−9 : Rhodamine B Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 81−88−9 : Rhodamine B Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 81−90−3 : Phenolphthalin Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 81−90−3 : Phenolphthalin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 822−06−0 : 1,6−Diisocyanatohexane Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 822−06−0 : 1,6−Diisocyanatohexane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 82385−42−0 : Sodium saccharin hydrate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 82385−42−0 : Sodium saccharin hydrate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 824−39−5 : Sodium 2−nitrophenolate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 824−39−5 : Sodium 2−nitrophenolate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 82469−79−2 : Butyryl trihexyl citrate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 82469−79−2 : Butyryl trihexyl citrate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 824−78−2 : Sodium 4−nitrophenolate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 824−78−2 : Sodium 4−nitrophenolate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 82558−50−7 : Isoxaben Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 82558−50−7 : Isoxaben Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 825643−57−0 : PharmaGSID_48513 Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 825643−57−0 : PharmaGSID_48513 Agonist: 0 Antagonist: 0.17

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 82640−04−8 : Raloxifene hydrochloride Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 82640−04−8 : Raloxifene hydrochloride Agonist: 0 Antagonist: 0.085

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 82657−04−3 : Bifenthrin Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 82657−04−3 : Bifenthrin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 826−62−0 : 3a,4,7,7a−Tetrahydro−4,7−methanoisobenzofuran−1,3−dione Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 826−62−0 : 3a,4,7,7a−Tetrahydro−4,7−methanoisobenzofuran−1,3−dione Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 82−68−8 : Pentachloronitrobenzene Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 82−68−8 : Pentachloronitrobenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 827−19−0 : Sodium 2,5−dimethylbenzenesulfonate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 827−19−0 : Sodium 2,5−dimethylbenzenesulfonate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 827−21−4 : Benzenesulfonic acid, 2,4−dimethyl−, sodium salt Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 827−21−4 : Benzenesulfonic acid, 2,4−dimethyl−, sodium salt Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 828−00−2 : Dimethoxane Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 828−00−2 : Dimethoxane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 83−32−9 : Acenaphthene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 83−32−9 : Acenaphthene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 83−41−0 : 1,2−Dimethyl−3−nitrobenzene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 83−41−0 : 1,2−Dimethyl−3−nitrobenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 834−12−8 : Ametryn Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 834−12−8 : Ametryn Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 83657−24−3 : Diniconazole Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 83657−24−3 : Diniconazole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 83−67−0 : Theobromine Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 83−67−0 : Theobromine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 83−79−4 : Rotenone Chemical QC [ N.D. P P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 83−79−4 : Rotenone Agonist: 0 Antagonist: 0.00075

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 83834−59−7 : 2−Ethylhexyl trans−4−methoxycinnamate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 83834−59−7 : 2−Ethylhexyl trans−4−methoxycinnamate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 83−88−5 : Riboflavin Chemical QC [ ? N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 83−88−5 : Riboflavin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 838−85−7 : Diphenyl phosphate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 838−85−7 : Diphenyl phosphate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 838−88−0 : 4,4'−Methylenebis(2−methylaniline) Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 838−88−0 : 4,4'−Methylenebis(2−methylaniline) Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 84087−01−4 : Quinclorac Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 84087−01−4 : Quinclorac Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 84−16−2 : meso−Hexestrol Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 84−16−2 : meso−Hexestrol Agonist: 0 Antagonist: 0.13

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 842−07−9 : C.I. Solvent Yellow 14 Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 842−07−9 : C.I. Solvent Yellow 14 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 84371−65−3 : Mifepristone Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 84371−65−3 : Mifepristone Agonist: 0.038 Antagonist: 0.75

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 84−61−7 : Dicyclohexyl phthalate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 84−61−7 : Dicyclohexyl phthalate Agonist: 0 Antagonist: 0.018

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 84−66−2 : Diethyl phthalate Chemical QC [ ? P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 84−66−2 : Diethyl phthalate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 84−69−5 : Diisobutyl phthalate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 84−69−5 : Diisobutyl phthalate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 84−74−2 : Dibutyl phthalate Chemical QC [ P P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 84−74−2 : Dibutyl phthalate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 84−75−3 : Dihexyl phthalate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 84−75−3 : Dihexyl phthalate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 84852−15−3 : 4−Nonylphenol, branched Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 84852−15−3 : 4−Nonylphenol, branched Agonist: 0.023 Antagonist: 0.034

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 85−01−8 : Phenanthrene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 85−01−8 : Phenanthrene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 851916−42−2 : MK−812 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 851916−42−2 : MK−812 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 85264−33−1 : (3,5−Dimethyl−1H−pyrazol−1−yl)methanol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 85264−33−1 : (3,5−Dimethyl−1H−pyrazol−1−yl)methanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 85−40−5 : 1,2,3,6−Tetrahydrophthalimide Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 85−40−5 : 1,2,3,6−Tetrahydrophthalimide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 85−41−6 : Phthalimide Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 85−41−6 : Phthalimide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 85507−79−5 : Phthalic acid, diundecyl ester, branched and linear Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 85507−79−5 : Phthalic acid, diundecyl ester, branched and linear Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 85509−19−9 : Flusilazole Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 85509−19−9 : Flusilazole Agonist: 0 Antagonist: 0.13

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 85532−75−8 : PK 11195 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 85532−75−8 : PK 11195 Agonist: 0 Antagonist: 0.031

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 85−68−7 : Butyl benzyl phthalate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 85−68−7 : Butyl benzyl phthalate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 860−22−0 : C.I. Acid Blue 74 Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 860−22−0 : C.I. Acid Blue 74 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 862243−29−6 : AVE9423 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 862243−29−6 : AVE9423 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 86−30−6 : N−Nitrosodiphenylamine Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 86−30−6 : N−Nitrosodiphenylamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 86386−73−4 : Fluconazole Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 86386−73−4 : Fluconazole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 864283−48−7 : GSK232420A Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 864283−48−7 : GSK232420A Agonist: 0.57 Antagonist: 0.053

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 86479−06−3 : Hexaflumuron Chemical QC [ ? ? ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 86479−06−3 : Hexaflumuron Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 86−50−0 : Azinphos−methyl Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 86−50−0 : Azinphos−methyl Agonist: 0.0015 Antagonist: 0.09

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 86−73−7 : Fluorene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 86−73−7 : Fluorene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 86−87−3 : 1−Naphthaleneacetic acid Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 86−87−3 : 1−Naphthaleneacetic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 868−85−9 : Dimethyl hydrogen phosphite Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 868−85−9 : Dimethyl hydrogen phosphite Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87−01−4 : 7−(Dimethylamino)−4−methylcoumarin Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87−01−4 : 7−(Dimethylamino)−4−methylcoumarin Agonist: 0.058 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87−18−3 : 4−tert−Butylphenyl salicylate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87−18−3 : 4−tert−Butylphenyl salicylate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87−24−1 : Ethyl 2−methylbenzoate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87−24−1 : Ethyl 2−methylbenzoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 872−50−4 : N−Methyl−2−pyrrolidone Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 872−50−4 : N−Methyl−2−pyrrolidone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87−25−2 : Ethyl anthranilate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87−25−2 : Ethyl anthranilate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87392−12−9 : S−Metolachlor Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87392−12−9 : S−Metolachlor Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87546−18−7 : Flumiclorac−pentyl Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87546−18−7 : Flumiclorac−pentyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87−61−6 : 1,2,3−Trichlorobenzene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87−61−6 : 1,2,3−Trichlorobenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87−62−7 : 2,6−Dimethylaniline Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87−62−7 : 2,6−Dimethylaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87674−68−8 : Dimethenamid Chemical QC [ ? P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87674−68−8 : Dimethenamid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87−68−3 : Hexachloro−1,3−butadiene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87−68−3 : Hexachloro−1,3−butadiene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87−69−4 : L−Tartaric acid Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87−69−4 : L−Tartaric acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 877−24−7 : Monopotassium phthalate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 877−24−7 : Monopotassium phthalate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87818−31−3 : Cinmethylin Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87818−31−3 : Cinmethylin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87820−88−0 : Tralkoxydim Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87820−88−0 : Tralkoxydim Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87−86−5 : Pentachlorophenol Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87−86−5 : Pentachlorophenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87−90−1 : Symclosene Chemical QC [ N.D. N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 87−90−1 : Symclosene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−04−0 : 4−Chloro−3,5−dimethylphenol Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−04−0 : 4−Chloro−3,5−dimethylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−06−2 : 2,4,6−Trichlorophenol Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−06−2 : 2,4,6−Trichlorophenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−12−0 : N−Vinyl−2−pyrrolidone Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−12−0 : N−Vinyl−2−pyrrolidone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−18−6 : 2−tert−Butylphenol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−18−6 : 2−tert−Butylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−24−4 : 2,2'−Methylenebis(ethyl−6−tert−butylphenol) Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−24−4 : 2,2'−Methylenebis(ethyl−6−tert−butylphenol) Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−30−2 : 3−Trifluoromethyl−4−nitrophenol Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−30−2 : 3−Trifluoromethyl−4−nitrophenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−41−5 : 2−tert−Butylcyclohexyl acetate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−41−5 : 2−tert−Butylcyclohexyl acetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−58−4 : 2,5−Di−tert−butylbenzene−1,4−diol Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−58−4 : 2,5−Di−tert−butylbenzene−1,4−diol Agonist: 0 Antagonist: 0.038

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−60−8 : 2−tert−Butyl−5−methylphenol Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−60−8 : 2−tert−Butyl−5−methylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88671−89−0 : Myclobutanil Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88671−89−0 : Myclobutanil Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−69−7 : 2−Isopropylphenol Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−69−7 : 2−Isopropylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−72−2 : 2−Nitrotoluene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−72−2 : 2−Nitrotoluene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−74−4 : 2−Nitroaniline Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−74−4 : 2−Nitroaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−75−5 : 2−Nitrophenol Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−75−5 : 2−Nitrophenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−85−7 : Dinoseb Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 88−85−7 : Dinoseb Agonist: 0 Antagonist: 0.034

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 89−04−3 : Trioctyl trimellitate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 89−04−3 : Trioctyl trimellitate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 89−71−4 : Methyl 2−methylbenzoate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 89−71−4 : Methyl 2−methylbenzoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 89−72−5 : 2−(Butan−2−yl)phenol Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 89−72−5 : 2−(Butan−2−yl)phenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 89−78−1 : dl−Menthol Chemical QC [ ? N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 89−78−1 : dl−Menthol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 89−83−8 : Thymol Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 89−83−8 : Thymol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 89−87−2 : 1,3−Dimethyl−4−nitrobenzene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 89−87−2 : 1,3−Dimethyl−4−nitrobenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 90−00−6 : 2−Ethylphenol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 90−00−6 : 2−Ethylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 90−02−8 : Salicylaldehyde Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 90−02−8 : Salicylaldehyde Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 9003−11−6 : Pluronic F−127 Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 9003−11−6 : Pluronic F−127 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 90−04−0 : 2−Anisidine Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 90−04−0 : 2−Anisidine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 9004−82−4 : Sodium lauryl polyoxyethylene ether sulfate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 9004−82−4 : Sodium lauryl polyoxyethylene ether sulfate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 9004−96−0 : Polyoxyethylene monoleate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 9004−96−0 : Polyoxyethylene monoleate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 90−05−1 : 2−Methoxyphenol Chemical QC [ N.D. P P−MW P−MW ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 90−05−1 : 2−Methoxyphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 9005−65−6 : Polysorbate 80 Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 9005−65−6 : Polysorbate 80 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 90−12−0 : 1−Methylnaphthalene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 90−12−0 : 1−Methylnaphthalene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 90−15−3 : 1−Naphthol Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 90−15−3 : 1−Naphthol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 9016−00−6 : Polydimethylsiloxane Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 9016−00−6 : Polydimethylsiloxane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 9016−87−9 : Isocyanic acid, polymethylenepolyphenylene ester Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 9016−87−9 : Isocyanic acid, polymethylenepolyphenylene ester Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 90−30−2 : N−Phenyl−1−naphthylamine Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 90−30−2 : N−Phenyl−1−naphthylamine Agonist: 0 Antagonist: 0.021

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 90357−06−5 : Bicalutamide Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 90357−06−5 : Bicalutamide Agonist: 0.0044 Antagonist: 0.35

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 90−43−7 : 2−Phenylphenol Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 90−43−7 : 2−Phenylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 90−72−2 : 2,4,6−Tris(dimethylaminomethyl)phenol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 90−72−2 : 2,4,6−Tris(dimethylaminomethyl)phenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 90823−38−4 : Denatonium saccharide Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 90823−38−4 : Denatonium saccharide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 90−94−8 : Michler's ketone Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 90−94−8 : Michler's ketone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 91082−17−6 : C10−21 sulfonic acids phenyl esters Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 91082−17−6 : C10−21 sulfonic acids phenyl esters Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 91−20−3 : Naphthalene Chemical QC [ ? N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 91−20−3 : Naphthalene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 91−22−5 : Quinoline Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 91−22−5 : Quinoline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 91465−08−6 : lambda−Cyhalothrin Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 91465−08−6 : lambda−Cyhalothrin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 91−53−2 : Ethoxyquin Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 91−53−2 : Ethoxyquin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 91−59−8 : 2−Naphthylamine Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 91−59−8 : 2−Naphthylamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 91−62−3 : 6−Methylquinoline Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 91−62−3 : 6−Methylquinoline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 91−64−5 : Coumarin Chemical QC [ N.D. N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 91−64−5 : Coumarin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 91−66−7 : N,N−Diethylaniline Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 91−66−7 : N,N−Diethylaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 919−30−2 : 3−Aminopropyltriethoxysilane Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 919−30−2 : 3−Aminopropyltriethoxysilane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 92−04−6 : 2−Chloro−4−phenylphenol Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 92−04−6 : 2−Chloro−4−phenylphenol Agonist: 0.024 Antagonist: 0.12

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 924−16−3 : N−Nitrosodibutylamine Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 924−16−3 : N−Nitrosodibutylamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 92−52−4 : Biphenyl Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 92−52−4 : Biphenyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 92−68−2 : 4−Cyclohexylcyclohexanone Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 92−68−2 : 4−Cyclohexylcyclohexanone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 92−69−3 : 4−Phenylphenol Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 92−69−3 : 4−Phenylphenol Agonist: 0.018 Antagonist: 0.12

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 92−84−2 : Phenothiazine Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 92−84−2 : Phenothiazine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 92−87−5 : Benzidine Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 92−87−5 : Benzidine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 928−96−1 : (Z)−3−Hexen−1−ol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 928−96−1 : (Z)−3−Hexen−1−ol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 929−59−9 : 2,2'−[Ethane−1,2−diylbis(oxy)]diethanamine Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 929−59−9 : 2,2'−[Ethane−1,2−diylbis(oxy)]diethanamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 929601−09−2 : SR58611 Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 929601−09−2 : SR58611 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 930−55−2 : N−Nitrosopyrrolidine Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 930−55−2 : N−Nitrosopyrrolidine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 93−08−3 : 2'−Acetonaphthone Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 93−08−3 : 2'−Acetonaphthone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 93−15−2 : Methyleugenol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 93−15−2 : Methyleugenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 93−56−1 : Styrene glycol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 93−56−1 : Styrene glycol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 93−65−2 : Mecoprop Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 93−65−2 : Mecoprop Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 93−76−5 : 2,4,5−Trichlorophenoxyacetic acid Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 93−76−5 : 2,4,5−Trichlorophenoxyacetic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 938−16−9 : tert−Butyl phenyl ketone Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 938−16−9 : tert−Butyl phenyl ketone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 93−89−0 : Ethyl benzoate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 93−89−0 : Ethyl benzoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 93−92−5 : Benzenemethanol, alpha−methyl−, acetate Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 93−92−5 : Benzenemethanol, alpha−methyl−, acetate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 93−99−2 : Phenyl benzoate Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 93−99−2 : Phenyl benzoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−08−6 : Ethyl 4−methylbenzoate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−08−6 : Ethyl 4−methylbenzoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−09−7 : Benzocaine Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−09−7 : Benzocaine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−13−3 : Propylparaben Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−13−3 : Propylparaben Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 941−69−5 : 1−Phenyl−1H−pyrrole−2,5−dione Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 941−69−5 : 1−Phenyl−1H−pyrrole−2,5−dione Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−18−8 : Benzylparaben Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−18−8 : Benzylparaben Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−26−8 : Butylparaben Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−26−8 : Butylparaben Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−28−0 : Triethylene glycol bis(2−ethylhexanoate) Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−28−0 : Triethylene glycol bis(2−ethylhexanoate) Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94361−06−5 : Cyproconazole Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94361−06−5 : Cyproconazole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−46−2 : Isopentyl benzoate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−46−2 : Isopentyl benzoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−47−3 : 2−Phenylethyl benzoate Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−47−3 : 2−Phenylethyl benzoate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−59−7 : Safrole Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−59−7 : Safrole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−60−0 : Dimethyl hexahydroterephthalate Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−60−0 : Dimethyl hexahydroterephthalate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−71−3 : 2−Ethoxyphenol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−71−3 : 2−Ethoxyphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−74−6 : MCPA Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−74−6 : MCPA Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−75−7 : 2,4−Dichlorophenoxyacetic acid Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−75−7 : 2,4−Dichlorophenoxyacetic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−80−4 : 2,4−D 1−butyl ester Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−80−4 : 2,4−D 1−butyl ester Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−81−5 : MCPB Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−81−5 : MCPB Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−82−6 : 2,4−DB Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−82−6 : 2,4−DB Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−91−7 : N,N'−Disalicylidene−1,2−diaminopropane Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−91−7 : N,N'−Disalicylidene−1,2−diaminopropane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−96−2 : 2−Ethyl−1,3−hexanediol Chemical QC [ N.D. N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 94−96−2 : 2−Ethyl−1,3−hexanediol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 950−37−8 : Methidathion Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 950−37−8 : Methidathion Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−13−6 : Indene Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−13−6 : Indene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−14−7 : 1,2,3−Benzotriazole Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−14−7 : 1,2,3−Benzotriazole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−16−9 : Benzothiazole Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−16−9 : Benzothiazole Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95266−40−3 : Trinexapac−ethyl Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95266−40−3 : Trinexapac−ethyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−38−5 : 1H−Imidazole−1−ethanol, 2−(8−heptadecenyl)−4,5−dihydro− Chemical QC [ ? ? ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−38−5 : 1H−Imidazole−1−ethanol, 2−(8−heptadecenyl)−4,5−dihydro− Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−48−7 : o−Cresol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−48−7 : o−Cresol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−49−8 : 2−Chlorotoluene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−49−8 : 2−Chlorotoluene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−50−1 : 1,2−Dichlorobenzene Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−50−1 : 1,2−Dichlorobenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−53−4 : 2−Methylaniline Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−53−4 : 2−Methylaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−54−5 : 1,2−Phenylenediamine Chemical QC [ ? ? ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−54−5 : 1,2−Phenylenediamine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−57−8 : 2−Chlorophenol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−57−8 : 2−Chlorophenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−63−6 : 1,2,4−Trimethylbenzene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−63−6 : 1,2,4−Trimethylbenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−65−8 : 3,4−Dimethylphenol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−65−8 : 3,4−Dimethylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95737−68−1 : Pyriproxyfen Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95737−68−1 : Pyriproxyfen Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−74−9 : 3−Chloro−4−methylaniline Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−74−9 : 3−Chloro−4−methylaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 957−51−7 : Diphenamid Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 957−51−7 : Diphenamid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−76−1 : 3,4−Dichloroaniline Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−76−1 : 3,4−Dichloroaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−80−7 : 2,4−Diaminotoluene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−80−7 : 2,4−Diaminotoluene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−83−0 : 4−Chloro−1,2−diaminobenzene Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−83−0 : 4−Chloro−1,2−diaminobenzene Agonist: 0.018 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−87−4 : 2,5−Dimethylphenol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−87−4 : 2,5−Dimethylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−93−2 : 1,2,4,5−Tetramethylbenzene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−93−2 : 1,2,4,5−Tetramethylbenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−94−3 : 1,2,4,5−Tetrachlorobenzene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−94−3 : 1,2,4,5−Tetrachlorobenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−95−4 : 2,4,5−Trichlorophenol Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 95−95−4 : 2,4,5−Trichlorophenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 959−98−8 : Endosulfan I Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 959−98−8 : Endosulfan I Agonist: 0 Antagonist: 0.015

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 960−71−4 : Triphenylborane Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 960−71−4 : Triphenylborane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 96−09−3 : Styrene oxide Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 96−09−3 : Styrene oxide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 96182−53−5 : Tebupirimfos Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 96182−53−5 : Tebupirimfos Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 96−18−4 : 1,2,3−Trichloropropane Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 96−18−4 : 1,2,3−Trichloropropane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 96−23−1 : 1,3−Dichloro−2−propanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 96−23−1 : 1,3−Dichloro−2−propanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 96−24−2 : 3−Chloro−1,2−propanediol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 96−24−2 : 3−Chloro−1,2−propanediol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 962−58−3 : Diazoxon Chemical QC [ ? N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 962−58−3 : Diazoxon Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 96−29−7 : 2−Butanone oxime Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 96−29−7 : 2−Butanone oxime Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 96−41−3 : Cyclopentanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 96−41−3 : Cyclopentanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 96−45−7 : Ethylene thiourea Chemical QC [ N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 96−45−7 : Ethylene thiourea Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 96−48−0 : 4−Butyrolactone Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 96−48−0 : 4−Butyrolactone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 96489−71−3 : Pyridaben Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 96489−71−3 : Pyridaben Agonist: 0 Antagonist: 0.045

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 96−70−8 : 2−tert−Butyl−4−ethylphenol Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 96−70−8 : 2−tert−Butyl−4−ethylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 96−76−4 : 2,4−Di−tert−butylphenol Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 96−76−4 : 2,4−Di−tert−butylphenol Agonist: 0.019 Antagonist: 0.028

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 96−83−3 : Iopanoic acid Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 96−83−3 : Iopanoic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 97−00−7 : 1−Chloro−2,4−dinitrobenzene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 97−00−7 : 1−Chloro−2,4−dinitrobenzene Agonist: 0 Antagonist: 0.13

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 97−23−4 : Dichlorophen Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 97−23−4 : Dichlorophen Agonist: 0 Antagonist: 0.16

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 97322−87−7 : Troglitazone Chemical QC [ N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 97322−87−7 : Troglitazone Agonist: 0 Antagonist: 0.03

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 97−52−9 : 2−Methoxy−4−nitroaniline Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 97−52−9 : 2−Methoxy−4−nitroaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 97−53−0 : Eugenol Chemical QC [ ? N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 97−53−0 : Eugenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 97−54−1 : Isoeugenol Chemical QC [ ? ? ? N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 97−54−1 : Isoeugenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 97−56−3 : 2−Amino−5−azotoluene Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 97−56−3 : 2−Amino−5−azotoluene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 97−59−6 : Allantoin Chemical QC [ N.D. N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 97−59−6 : Allantoin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 97−77−8 : Disulfiram Chemical QC [ N.D. P P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 97−77−8 : Disulfiram Agonist: 0 Antagonist: 0.1

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 97−78−9 : N−Dodecanoyl−N−methylglycine Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 97−78−9 : N−Dodecanoyl−N−methylglycine Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 97886−45−8 : Dithiopyr Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 97886−45−8 : Dithiopyr Agonist: 0 Antagonist: 0.042

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 97−99−4 : Tetrahydrofurfuryl alcohol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 97−99−4 : Tetrahydrofurfuryl alcohol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98−00−0 : Furfuryl alcohol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98−00−0 : Furfuryl alcohol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98−01−1 : Furfural Chemical QC [ N.D. N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98−01−1 : Furfural Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98−06−6 : tert−Butylbenzene Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98−06−6 : tert−Butylbenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98−07−7 : Benzotrichloride Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98−07−7 : Benzotrichloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98319−26−7 : Finasteride Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98319−26−7 : Finasteride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98−51−1 : 4−tert−Butyltoluene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98−51−1 : 4−tert−Butyltoluene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98−52−2 : 4−tert−Butylcyclohexanol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98−52−2 : 4−tert−Butylcyclohexanol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98−53−3 : 4−tert−Butylcyclohexanone Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98−53−3 : 4−tert−Butylcyclohexanone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98−54−4 : 4−tert−Butylphenol Chemical QC [ N.D. N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98−54−4 : 4−tert−Butylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98−56−6 : 1−Chloro−4−(trifluoromethyl)benzene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98−56−6 : 1−Chloro−4−(trifluoromethyl)benzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98730−04−2 : Benoxacor Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98730−04−2 : Benoxacor Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98−86−2 : Acetophenone Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98−86−2 : Acetophenone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98−87−3 : Benzal chloride Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98−87−3 : Benzal chloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98886−44−3 : Fosthiazate Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98886−44−3 : Fosthiazate Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98−92−0 : Niacinamide Chemical QC [ N.D. N.D. P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98−92−0 : Niacinamide Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 989−38−8 : Rhodamine 6G Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 989−38−8 : Rhodamine 6G Agonist: 0 Antagonist: 4e−04

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98−95−3 : Nitrobenzene Chemical QC [ ? N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98−95−3 : Nitrobenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98967−40−9 : Flumetsulam Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 98967−40−9 : Flumetsulam Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−07−0 : 3−Dimethylaminophenol Chemical QC [ N.D. P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−07−0 : 3−Dimethylaminophenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−08−1 : 3−Nitrotoluene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−08−1 : 3−Nitrotoluene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−30−9 : Dicloran Chemical QC [ P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−30−9 : Dicloran Agonist: 0 Antagonist: 0.088

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−51−4 : 1,2−Dimethyl−4−nitrobenzene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−51−4 : 1,2−Dimethyl−4−nitrobenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−54−7 : 3,4−Dichloronitrobenzene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−54−7 : 3,4−Dichloronitrobenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−55−8 : 2−Methyl−5−nitroaniline Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−55−8 : 2−Methyl−5−nitroaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−59−2 : 2−Methoxy−5−nitroaniline Chemical QC [ N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−59−2 : 2−Methoxy−5−nitroaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99607−70−2 : Cloquintocet−mexyl Chemical QC [ P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99607−70−2 : Cloquintocet−mexyl Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−62−7 : 1,3−Diisopropylbenzene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−62−7 : 1,3−Diisopropylbenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−63−8 : 1,3−Benzenedicarbonyl dichloride Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−63−8 : 1,3−Benzenedicarbonyl dichloride Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−65−0 : 1,3−Dinitrobenzene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−65−0 : 1,3−Dinitrobenzene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−66−1 : Valproic acid Chemical QC [ N.D. N.D. N.D. N.D. P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−66−1 : Valproic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−71−8 : 4−(Butan−2−yl)phenol Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−71−8 : 4−(Butan−2−yl)phenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−76−3 : Methylparaben Chemical QC [ N.D. P P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−76−3 : Methylparaben Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−85−4 : gamma−Terpinene Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−85−4 : gamma−Terpinene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−86−5 : alpha−Terpinene Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−86−5 : alpha−Terpinene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−87−6 : p−Cymene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−87−6 : p−Cymene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−89−8 : 4−Isopropylphenol Chemical QC [ N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−89−8 : 4−Isopropylphenol Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−93−4 : 4−Hydroxyacetophenone Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−93−4 : 4−Hydroxyacetophenone Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−96−7 : 4−Hydroxybenzoic acid Chemical QC [ P P P ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−96−7 : 4−Hydroxybenzoic acid Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−97−8 : N,N,4−Trimethylaniline Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−97−8 : N,N,4−Trimethylaniline Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−99−0 : 4−Nitrotoluene Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 99−99−0 : 4−Nitrotoluene Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 999−97−3 : Hexamethyldisilazane Chemical QC [ N.D. N.D. N.D. ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 999−97−3 : Hexamethyldisilazane Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_34742 : Milbemectin (mixture of 70% Milbemcin A4, 30% Milbemycin A3) Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_34742 : Milbemectin (mixture of 70% Milbemcin A4, 30% Milbemycin A3) Agonist: 0 Antagonist: 0.084

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47248 : CI−1018 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47248 : CI−1018 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47255 : CP−465394 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47255 : CP−465394 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47265 : CP−471358 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47265 : CP−471358 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47267 : CP−642931 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47267 : CP−642931 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47291 : CI−1044 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47291 : CI−1044 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47292 : PD 0200347 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47292 : PD 0200347 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47299 : CP−422935 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47299 : CP−422935 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47305 : CP−608039 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47305 : CP−608039 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47311 : GSK163929B Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47311 : GSK163929B Agonist: 0 Antagonist: 0.17

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47325 : SB413217A Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47325 : SB413217A Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47328 : MK−274 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47328 : MK−274 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47330 : PharmaGSID_47330 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47330 : PharmaGSID_47330 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47333 : PharmaGSID_47333 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47333 : PharmaGSID_47333 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47334 : MK−968 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47334 : MK−968 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47342 : SR125047 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47342 : SR125047 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47346 : SSR162369 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47346 : SSR162369 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47351 : SSR240612 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47351 : SSR240612 Agonist: 0.00055 Antagonist: 0.29

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47353 : SSR241586 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47353 : SSR241586 Agonist: 0 Antagonist: 0.097

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47362 : SSR150106 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47362 : SSR150106 Agonist: 0 Antagonist: 0.015

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47364 : SSR103800 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47364 : SSR103800 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47366 : SAR115740 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47366 : SAR115740 Agonist: 0 Antagonist: 0.071

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47374 : SSR161421 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47374 : SSR161421 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47377 : AVE6324 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47377 : AVE6324 Agonist: 0 Antagonist: 0.12

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47379 : SSR126768 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47379 : SSR126768 Agonist: 0.00039 Antagonist: 0.18

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47383 : AVE3247 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47383 : AVE3247 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47385 : SAR377142 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47385 : SAR377142 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47387 : SAR102779 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47387 : SAR102779 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47389 : SAR150640 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47389 : SAR150640 Agonist: 0 Antagonist: 6e−07

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47708 : Igepal CO−890 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47708 : Igepal CO−890 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47796 : Formalin Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_47796 : Formalin Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_48172 : PharmaGSID_48172 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_48172 : PharmaGSID_48172 Agonist: 0 Antagonist: 0.016

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_48176 : YM218 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_48176 : YM218 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_48505 : PharmaGSID_48505 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_48505 : PharmaGSID_48505 Agonist: 0 Antagonist: 0.061

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_48507 : PharmaGSID_48507 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_48507 : PharmaGSID_48507 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_48509 : PharmaGSID_48509 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_48509 : PharmaGSID_48509 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_48514 : PharmaGSID_48514 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_48514 : PharmaGSID_48514 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_48516 : PharmaGSID_48516 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_48516 : PharmaGSID_48516 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_48518 : PharmaGSID_48518 Chemical QC [ ]

Concentration (uM)Efficacy − fraction(E2)

1e−02 1e−01 1e+00 1e+01 1e+020.00.20.40.60.81.0 NOCAS_48518 : PharmaGSID_48518 Agonist: 0 Antagonist: 0

Concentration (uM)Receptor Score